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Executive Summary 
In Switzerland, the utilization of vitamin D tests has increased over 100-fold since 2006, leading to 
substantial increases in costs. Although vitamin D supplementation is recommended in clinical prac-
tice, the benefits of vitamin D testing prior to vitamin D supplementation remain unknown.  
We conducted a systematic literature search to identify the clinical and economic evidence related 
to testing for vitamin D for at-risk groups defined by the Swiss Federal Commission of Nutrition 
(FCN). We further examined the literature regarding the clinical effect of vitamin D supplementation 
in the same at-risk groups. If no benefit from supplementation can be shown, then benefits of testing 
can be ruled out, if these tests aim to inform the decision to supplement.   
In regards to vitamin D testing for the defined at-risk groups (persons with bone disorders, older 
adults, obese individuals, pregnant women, people with dark skin, and athletes), no primary studies 
were identified which assess health outcomes.  
Economic results for testing in older adults were mixed and non-conclusive. In one study, it was 
estimated that for older people as well as for people with darker skin, overall costs are lower if 
supplementation of vitamin D without prior vitamin D testing is given instead of implementing a vit-
amin D testing and treatment strategy.  
In regards to vitamin D supplementation, we pursued a systematic but non-comprehensive approach 
to the literature search and selection, which carries a potential risk of bias. On this basis, the evi-
dence on effectiveness of vitamin D supplementation was generally mixed and not conclusive.  
Based on the scoping report the feasibility to produce a full HTA has been considered. A full HTA 
would not be justified at present due to the absence of clinical studies evaluating vitamin D testing. 
Only after such studies have become available could the topic be re-considered. Vitamin D testing 
is recommended for patients where it is medically necessary, and this is not disputed in the present 
report. The lack of available evidence for vitamin D testing for defined at-risk groups from our review, 
could be informative in guiding a decision policy on vitamin D testing. 
 
Zusammenfassung: 
In der Schweiz hat der Einsatz von Vitamin-D-Tests seit 2006 um mehr als das Hundertfache zuge-
nommen, was zu erheblichen Kostenanstiegen geführt hat. Obwohl eine Vitamin-D-Supplementie-
rung in der klinischen Praxis empfohlen wird, ist der Nutzen von Vitamin-D-Tests vor einer Vitamin-
D-Supplementierung nicht bekannt.  
Wir führten eine systematische Literaturrecherche durch, um die klinische und wirtschaftliche Evidenz 
von Vitamin-D-Tests für von der Eidgenössischen Ernährungskommission (EEK) definierte Risiko-
gruppen zu ermitteln. Ferner analysierten wir die Literatur zur klinischen Wirkung einer Vitamin-D-
Supplementierung bei denselben Risikogruppen. Wenn kein Nutzen einer Supplementierung nach-
gewiesen werden kann, lässt sich ein Nutzen der Tests ausschliessen, sofern aufgrund dieser Tests 
die Entscheidung zur Supplementierung getroffen werden soll.   
Hinsichtlich der Vitamin-D-Tests für die definierten Risikogruppen (Personen mit Knochenerkrankun-
gen, ältere Erwachsene, adipöse Personen, Schwangere, Menschen mit dunkler Haut sowie Sport-
lerinnen und Sportler) wurden keine Primärstudien ermittelt, die den gesundheitlichen Nutzen beur-
teilen.  
Die ökonimischen Ergebnisse des Testens älterer Erwachsener waren gemischt und nicht schlüssig. 
In einer Studie wurde davon ausgegangen, dass sowohl bei älteren Menschen als auch bei Menschen 
mit dunkler Haut die Gesamtkosten niedriger sind, wenn eine Vitamin-D-Supplementierung ohne vor-
herigen Vitamin-D-Test erfolgt und keine Vitamin-D-Test- und -Behandlungsstrategie zur Anwendung 
gelangt.  
In Bezug auf die Vitamin-D-Supplementierung verfolgten wir bei der Literaturrecherche und -auswahl 
einen systematischen, aber nicht umfassenden Ansatz, der ein potenzielles Risiko für Verzerrung 
(Bias) birgt. Auf dieser Grundlage war die Evidenz zur Effektivität einer Vitamin-D-Supplementierung 
im Allgemeinen gemischt und nicht schlüssig.  
Aufgrund des Scoping-Berichts wurde die Durchführbarkeit eines vollständigen HTAs erwogen. Ein 
vollständiges HTA wäre derzeit nicht gerechtfertigt, da es keine klinischen Studien zur Bewertung 
von Vitamin-D-Tests gibt. Erst nach Vorliegen solcher Studien könnte das Thema neu angegangen 
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werden. Vitamin-D-Tests werden für Patientinnen und Patienten empfohlen, bei denen sie medizi-
nisch notwendig sind, und dies wird im vorliegenden Bericht nicht bestritten. Der bei unserer Litera-
turstudie festgestellte Mangel an verfügbarer Evidenz für Vitamin-D-Tests für definierte Risikogrup-
pen könnte aufschlussreich sein, eine Entscheidungsstrategie für Vitamin-D-Tests zu leiten. 
 
Résumé: 
En Suisse, les recours aux tests pour mesurer le taux de vitamine D ont été multipliés par plus de 
100 depuis 2006, entraînant une hausse considérable des coûts. Bien que l’apport complémentaire 
en vitamine D soit recommandé en pratique clinique, les avantages de procéder à un test avant la 
supplémentation elle-même demeurent inconnus.  
Nous avons mené une recherche systématique dans la littérature pour identifier les preuves cliniques 
et économiques relatives au dépistage d’une éventuelle carence en vitamine D dans des groupes à 
risque définis par la Commission fédérale de la nutrition (CFN). Nous avons également examiné la 
littérature concernant l’effet clinique de l’apport en vitamine D dans ces mêmes groupes à risque. Au 
cas où il n’etait pas possible de démontrer un bénéfice clinique pour ce qui est de la supplémentation, 
il serait alors également possible d’exclure un bénéfice clinique pour la mesure du taux de vitamine 
D pour les cas où celle-ci sert de base à la décision de supplémentation.   
Concernant les tests pour la vitamine D dans les groupes à risque définis (personnes atteintes de 
troubles osseux, personnes âgées, personnes souffrant d’obésité, femmes enceintes, personnes 
ayant la peau sombre et athlètes), nous n’avons identifié aucune étude primaire évaluant les résultats 
en matière de santé. 
Les résultats économiques pour les tests réalisés au sein de la population âgée étaient mitigés et 
non concluants. Une étude estimait que, tant pour les personnes âgées que pour les personnes avec 
une peau sombre, la supplémentation en vitamine D administrée sans test préalable entraînait des 
coûts totaux moins élevés que si la stratégie mise en place incluait test et traitement.  
Pour l’apport supplémentaire en vitamine D, nous avons, lors de notre recherche et de notre sélec-
tion, opté pour une approche systématique mais non exhaustive qui comporte un risque de biais. À 
partir de là, les preuves de l’efficacité de la supplémentation en vitamine D étaient généralement 
mitigées et non concluantes.  
Sur la base du rapport de scoping, la faisabilité de produire un rapport HTA complet a été considérée. 
Un HTA complet ne serait pour l’instant pas justifié étant donné le manque d’études cliniques consa-
crées aux tests de dépistage pour la vitamine D. Ce sujet ne pourra être réexaminé qu’une fois que 
de telles études seront disponibles. Les tests pour la vitamine D sont recommandés aux patients pour 
lesquels ils s’avèrent médicalement nécessaires, et le présent rapport ne conteste aucunement ce 
fait. Le manque de preuves disponibles concernant les tests de dosage de la vitamine D pour les 
groupes à risque définis pourrait constituer une information utile afin d’orienter une politique de déci-
sion quant auxdits tests.  
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Objective of the HTA Scoping Report 
The objective of the scoping report on vitamin D testing is to conduct a systematic literature search and 
to synthesize the available evidence base addressing the main health technology assessment (HTA) 
domains. A central research question is presented and a systematic literature search is conducted to 
determine whether sufficient evidence is available to conduct a full HTA. The main focus of the literature 
search is to identify studies evaluating clinical effectiveness and economic impact of vitamin D testing. 
A second objective is to identify studies evaluating clinical effectiveness of vitamin D supplementation. 
Operational key questions covering the EUnetHTA main Core-Model domains, i.e. clinical effective-
ness/safety, costs/budget impact/cost-effectiveness, legal/social/ ethical and organisational issues are 
formulated. The target population(s), the appropriate comparator and the relevant health outcomes are 
defined. In the report the analytical methods that are to be used when a HTA is pursued are described. 
Based on quantity and quality of the extracted evidence the feasibility of pursuing a HTA is judged. 
Analysis of the individual study outcomes is not the objective of the scoping report. 
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1. Policy Question 
The Federal Office of Public Health (FOPH) is reviewing the reimbursement by the Swiss compulsory 
insurance of vitamin D testing compared to no vitamin D testing and/or supplementation of vitamin D 
without prior vitamin D testing in defined risk groups because the clinical utility of vitamin D testing has 
been questioned. Currently, vitamin D testing is reimbursed by the Swiss compulsory health insurance 
for any individual regardless of their level of deficiency risk. 
This report from FOPH aims to evaluate the available clinical and economic evidence on vitamin D 
testing. Over the last 10 years, the amount of prescriptions for vitamin D testing has increased steadily 
in Switzerland, leading to substantial increases in costs.  
In a report by the Federal Commission of Nutrition (FCN), it was recommended that vitamin D testing is 
undertaken in groups at high risk of severe vitamin D deficiency 1.  
Questions have been raised about the clinical utility of vitamin D testing prior to vitamin D supplemen-
tation. Supplementing without vitamin D testing is an alternative treatment pathway recommended in 
various western countries.    
Certain groups at risk may profit from vitamin D testing, as it may inform the decision of a physician of 
whether to prescribe a vitamin D supplement or not. Also the result of a vitamin D test can inform what 
the optimal vitamin D dose is for a patient according to his/her level of deficiency. In addition, the ques-
tion, which groups at risk profit from vitamin D supplementation, is a topic of ongoing debate.  
Therefore, simultaneously to addressing vitamin D testing, this scoping report extracts and presents 
available evidence supporting or not supporting a clinical benefit of vitamin D supplementation in certain 
groups at risk where FCN recommended vitamin D testing. If no benefit from supplementation can be 
shown, and if vitamin D tests aim to inform the decision to supplement, then benefits of testing can be 
ruled out a priori. This perspective becomes particularly relevant in the absence of evidence for testing. 
   
2. Research Question 
The central research question (CRQ) investigates: 
• the clinical utility and economic impact of vitamin D testing in groups at high risk of severe 
vitamin D deficiency. 
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3. Medical Background 
Vitamin D 
Vitamin D, also known as calciferol, is a liposoluble vitamin obtained either through synthesis in the skin 
through exposure to ultraviolet B (UVB) radiation from sunlight 2, or from dietary sources and 
supplements 3 4.  
Several forms of vitamin D exist, of which vitamin D2 or ergocalciferol and vitamin D3 or cholecalciferol 
are the most active forms. Vitamin D without a subscript refers to either D2 or D3 or both. Vitamin D2 is 
derived from plants while vitamin D3 is derived from animal sources and exposure to sunlight which is 
the main source 5. Naturally vitamin D rich foods include fatty fish (salmon, tuna, sardines etc.), egg 
yolks, fish liver oil and certain types of mushrooms 3 6. Fortified foods (although banned in several 
countries) such as milk and butter as well as sunlight exposure are more efficient vitamin D sources. 
Sunlight as source of vitamin D  is dependent on age, seasonality, sun exposure, skin pigmentation and 
sun protective means. It can be difficult  to obtain the recommended daily vitamin D intake from natural 
vitamin D sources only, therefore the use of vitamin D supplements may be necessary in certain 
subpopulations.  
Bone metabolism is characterized by continuous and lifelong bone formation and resorption 7. 
Particularly in childhood, bone metabolism is increased and adapted to the needs of skeletal growth 8. 
Vitamin D and calcium have a pivotal impact on bone health during pediatric age when nutritional rickets 
and impaired bone mass acquisition may occur. Besides these classic skeletal actions, recent studies 
have demonstrated that vitamin D exerts other significant extraskeletal actions.  
Vitamin D and calcium deficiencies impair bone density and muscle function  at any age, from childhood 
and adolescence onwards. Additionally negative effects on the immune system, diabetes incidence and 
cardio-metabolic function have been shown 9.   
   
Vitamin D Metabolism and Physiology 
Vitamin D from sunlight exposure, food or supplements first undergoes hydroxylation in the liver 
producing 25-hydroxyvitamin D. In the kidneys, a second hydroxylation occurs producing 1,25-
dihydroxyvitamin D, the active form of vitamin D 5. This step can also occur in the prostate, colon and 
breas2 10. Plasma parathyroid hormone (PTH), FGF23, serum calcium and phosphate levels regulate 
the renal synthesis of 1,25-dihydroxyvitamin D 11. 
The major role of vitamin D is to stimulate intestinal calcium and phosphate absorption. Adequate blood 
levels of calcium and phosphate are dependent on an adequate level of vitamin D 12 13. Calcium and 
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phosphate are important for bone growth, remodelling and mineralization, but also for other physiologic 
fonctions, such as muscle functioning  14. Therefore, calcium deficiency may also be responsible for 
muscle tetany, besides its negative effect on bone metabolism 15. The fine regulation of blood levels of 
calcium and phosphate depends additionally on hormones such as parathormone (PTH) and calcitonin 
16 17 .  
Vitamin D is also believed to be involved in the regulation of cell growth, differentation, apoptosis and 
metabolism 3 5 18 19. 
 
Figure 1. Vitamin D Synthesis and Metabolism 20 
 
Vitamin D Deficiency 
Various thresholds for vitamin D deficiency have been defined 1. The FCN classification is outlined in 
Table 1. 
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Table 1. Serum 25(OH)D Concentrations and Classifications 1 
 
Symptoms of Vitamin D deficiency 
Bone pain and muscle weakness, two symptoms associated with vitamin D deficiency, are rarely 
mentioned by the patient to the physician or recognized by the physician as beeing due to vitamin D 
deficiency 5. In adults, prolonged vitamin D deficiency is known to contribute to or exacerbate 
osteoporosis 5. Besides bone pain, the clinical presentation of osteoporosis is low trauma or spontanous 
bone fractures. Prologned vitamin D deficiency can also lead to osteomalacia in adults, characterized 
by bone softening  and muscle weakness 5. In children, prolonged vitamin D deficiency may cause brittle 
bones or rickets, the pediatric equivalent of osteomalacia caused by inadequate bone mineralization 
leading to soft bones and skeletal deformities 5. 
 
Vitamin D Supplementation and Vitamin D Testing 
Regarding to vitamin D testing, a distinction has to be made between the therapeutic setting and the 
preventive setting.  
In a therapeutic setting, when suspecting a vitamin D deficiency, testing of vitamin D may have its role 
in the diagnosis and the evaluation of the response to treatment.  
In the preventive setting, vitamin D testing is questioned. Testing is not an explicit prerequisite for vitamin 
D supplementation and physicians can prescribe vitamin D supplementation in order to prevent a vitamin 
D deficiency. Individuals may also get vitamin D supplements from their pharmacist or start vitamin D 
supplementation at their own initiative. Several specialized societies advise against the routine 
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screening of vitamin D status and recommend a strategy of primary prevention of deficiency through 
universal low-dose vitamin D supplementation for all young children and pregnant women 21-24. 
Supplementation with a dose of 600 to 800 IU of vitamin D per day is recommended for adults. Risks of 
overtreatment with vitamin D appear to be low and related immediate adverse effects (i.e. poisoning) 
are reported rarely 25-27. Most studies of vitamin D supplements have used doses of 400–1000 IU/day, 
have not been associated with evidence of adverse effects, and it is generally held that doses up to 
2000 IU/day are safe 28. However, recent literature has shown that high intermittent vitamin D 
supplementation (bolus doses) can increase the risk of falls and fractures 29.  
Vitamin D supplementation with or without calcium has been associated with various positive effects on 
health outcomes, in particular with respect to falls and fractures in elderly 30 31, muscle strength32, bone 
density 33 and physiological function 34 , type 2 diabetes mellitus 35 36, gestational diabetes 37, some types 
of cancer 35 38-41 but not all 42 43, overall mortality 44 as well as cancer-related mortality 43. Some studies 
report an effect on cardiovascular diseases 45 46 whereas some others do not 42 47. 
Although vitamin D supplementation with 800 IU per day is a recommended clinical practice, the benefits 
of compulsory testing in risk groups prior to supplementation remain unknown. One interest in vitamin 
D testing may be monitoring adherence to vitamin D supplementation. 
 
 
4. Technology 
4.1. Technology Description 
The vitamin D status of an individual can be determined on a regular blood draw by measuring serum 
concentrations of 25-hydroxyvitamin or of 1,25-dihydroxyvitamin D 48 49. Compared to 25-hydroxyvitamin 
D, 1,25-dihydroxyvitamin D has a short circulating half-life and lower serum concentrations, making it 
more difficult to measure. However, the level of 1,25-dihydroxyvitamin D still needs to be determined in 
some cases, such as renal failure, granuloma disorders as well as in some rare inborn errors of metab-
olism 48. 
There are different techniques available for measuring the serum levels of both forms of vitamin D (e.g. 
enzyme immunoassay, radioimmunoassay, high-performance liquid chromatography, liquid chromatog-
raphy-mass spectrometry and liquid chromatography-tandem mass spectrometry) 48 50 51.  
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Recommendations of the Federal Commission of Nutrition on Vitamin D Testing  
In Switzerland, FCN recommends vitamin D testing in individuals at high risk for severe vitamin D 
deficiency (<25 nmol/L). The FCN recommends vitamin D supplementation in all individuals with serum 
vitamin D levels below 50 nmol/L1. Subpopulations considered to be at high risk of severe vitamin D 
deficiency according to the FCN, are listed in Table 2. The FCN developed this list of subpopulations1 
by adapting the list of groups at high risk of severe vitamin D deficiency provided by the US Endocrine 
Society 21. No evidence is referenced by the FCN in their recommendation on testing 1.  
Table 2. Subject Groups at High Risk of Severe Vitamin D Deficiency according to FCN 1 
 
 
Costs of Vitamin D Testing 
In various countries, vitamin D testing has increased significantly over the last years 52-54. In Switzerland, 
the number of vitamin D tests has increased from about 9’500 in 2006 to about 1'179'000 in 2016. This 
increase is associated with a rise in costs to about CHF 60 million in 2016 (Figure 2, Source: SASIS 
Tarifpool). 
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Figure 2. Yearly Costs for Vitamin D Tests in Switzerland, 2006 - 2016 
 
Coverage Policy of Vitamin D Testing  
In Switzerland, the laboratory analyses for vitamin D reimbursed by the compulsory health insurance55 
are listed on the Analysenliste (list of laboratory analyses, annex 3 of the Krankenpflege-Leistungsver-
ordnung [KLV, SR 832.112.31]). The list contains 1,25-dihydroxy-cholecalciferol (position 1000.00) and 
the 25-hydroxy-vitamin-D (position 1006.00) 56. The position 1006.00 includes the measurement of the 
total level of serum vitamin D (vitamin D2 plus vitamin D3). Even if the level of vitamin D2 and D3 are 
not  measured simultaneously, the position 1006.00 can be only billed once on behalf of the compulsory 
health insurance 56. At present the reimbursement by the compulsory health insurance of vitamin D 
testing is not restricted to specific risk groups. 
In some countries, such as Canada, France or Germany, the reimbursement of vitamin D testing by 
health insurances has been limited to certain risk groups. For example, in Ontario, Canada, vitamin D 
testing reimbursement is restricted to persons with osteoporosis and osteopenia, rickets, malabsorption 
syndromes, renal disease, or persons on medications that affect vitamin D metabolism 57. In Alberta, 
Canada, the introduction of an additional criterion requiring clinicians to identify the medical indication 
for vitamin testing in a patient, led to a 92% reduction in the number of vitamin D tests 58. 
In France, vitamin D testing reimbursement is restricted to persons with rickets or osteomalacia, older 
adults with recurrent falls, monitoring of kidney transplant in adults and persons who have undergone 
bariatric surgery 59. 
In Germany, the statutory health insurance covers the vitamin D testing only if the medical necessity is 
given 60. Medical necessity is not further defined. The presence of a chronic disease such as bronchial 
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asthma or multiple sclerosis is not a reason for vitamin D testing coverage, but clinically manifest rickets 
or osteomalacia are.  
 
4.2. Alternative Technologies 
An alternative to vitamin D testing all subjects at high risk of severe vitamin D deficiency, as recom-
mended in the 2012 FCN report 1, is supplementing all high-risk individuals without prior vitamin D test-
ing.  
 
5. HTA key questions 
The aim of this scoping report is to explore a central research question (CRQ) on vitamin D testing; and 
also to explore an upstream research question (URQ) on vitamin D supplementation to select the ap-
propriate target groups for the CRQ. 
In order to evaluate the utility of vitamin D testing in a full HTA, one central research question and an 
upstream research question are formulated.  
The central research question (CRQ) investigates: 
• the clinical utility and economic impact of vitamin D testing in groups at high risk of severe 
vitamin D deficiency. Clinical utility is assessed in CRQa and economic impact in CRQb. 
 
5.1. Additional question 
The upstream research question (URQ) investigates: 
• clinical effectiveness of vitamin D supplementation in the FCN-defined subpopulations at high 
risk of severe vitamin D deficiency.  
 
6. PICOS 
Table 3  shows the PICOS covering clinical utility and economic impact of vitamin D testing and the 
PICOS for vitamin D supplementation. 
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6.1. Populations 
The different groups at high risk of severe vitamin D deficiency, as defined by the FCN 1, form the 
different target populations for the CRQ and URQ. We did not consider any other populations than those 
defined in the FCN report. For instance, we did not consider populations with asthma, COPD or multiple 
sclerosis. Although these groups may also be considered as having a high risk of severe vitamin D 
deficiency, they were not defined in the FCN report from 2012.  
Excluded are groups where vitamin D testing is medically necessary for diagnosing the following dis-
eases: osteoporosis, rickets, osteopenia, malabsorption syndromes, renal and hepatic diseases or gran-
uloma forming disorders. Persons using drugs affecting vitamin D metabolism, persons on chronic ster-
oid medication, and persons under strict medical treatment such as persons post organ transplantation 
and persons with cancer, cardiovascular disease, metabolic disorders (e.g. diabetes) and sickle cell 
anaemia are also excluded. In these groups vitamin D testing is not being questioned. Also for children 
with symptoms 1, or with an increased risk of vitamin D deficiency (e.g. children treated with classic anti-
epileptics 61, chronic intestine-, liver-, kidney diseases 62 63, during glucocorticoid therapy 64-66 or need 
for osteoporosis prophylaxis), 25-OH-D-measurement should be performed 67. The measurement of 
vitamin D levels in children at risk treated with pharmacological doses is advised to check correct 
dosage, compliance 68 and to prevent intoxications or nephrocalcinosis 25.   
6.2. Intervention 
The technology of interest is vitamin D testing, and there is a CRQa for clinical evidence for vitamin D 
testing and a CRQb for economic evidence of vitamin D testing.  
For the URQ vitamin D supplementation with or without calcium is the intervention. High dose intermit-
tent vitamin D supplementation (bolus doses for >1 month) are excluded, as depicted in the PICOS-Box 
in Table 3. High intermittent vitamin D supplementation has been associated with an increased risk of 
falls and fractures 28. This is why bolus studies of vitamin D supplementation have been excluded. It 
was beyond the scope of this report to consider certain factors, which may modify the effectiveness of 
vitamin D supplementation such as adherence and dosage, but we did consider the effect of co-admin-
istration of vitamin D with calcium. See keyword search strings for more details (Appendices 1-3). 
6.3. Comparator 
The technology chosen as comparator is no vitamin D testing/screening and /or vitamin D supplemen-
tation without prior testing of vitamin D for CRQa and CRQb. 
For the URQ the comparator is no vitamin D supplementation, which means placebo, no treatment or 
regular care for the URQ, as depicted in the PICOS-Box in Table 3. See keyword search strings for 
more details (Appendices 1-3). 
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6.4. Outcomes 
Clinical health outcomes for vitamin D testing and vitamin D supplementation are divided in bone health-
related and non-bone health-related outcomes. Outcomes related to bone health are e.g., rickets, oste-
omalacia, PTH (parathyroid hormone) concentrations, bone mineral density (BMD) or bone mineral con-
tent (BMC). Indirect bone health-related outcomes are fractures, muscle strength or physical perfor-
mance. Non-bone health-related outcomes can vary for each group at high risk of severe vitamin D 
deficiency defined by FCN.  
To address the CRQ, any health outcome is considered as depicted in the PICOS-Box in Table 3.  
To address the URQ, critical health-related outcomes per risk group were selected by clinical experts 
as depicted in Table 4. A nutritionist was also consulted for feedback on the selection of outcomes. 
6.5. Study Design 
For the CRQ, any comparative study was eligible for inclusion in our review. For the URQ only umbrella 
reviews (UR), HTA reports, SRs (including Cochrane reviews) and MAs (including network MAs/indirect 
treatment comparisons) were eligible for inclusion in our review, as depicted in the PICOS-Box in Table 
3. 
Table 3. PICOS-Box CRQ and URQ 
 CRQa: Vitamin D 
Testing (Clinical) 
CRQb: Vitamin D Test-
ing (Economic) 
URQ: Vitamin D Supple-
mentation (Clinical) 
Population  
• persons with bone disorders* 
• older adults (≥ 65yrs) 
• obese individuals 
• pregnant and lactating women 
• individuals with dark skin 
• athletes 
Intervention Vitamin D testing (clini-
cal) 
Vitamin D testing (econo-
mic) 
Vitamin D supplementa-
tion with or without cal-
cium (excluding high dose 
intermittent vitamin D sup-
plementation (>1 month)) 
Comparator No vitamin D test-
ing/screening; vitamin 
D supplementation 
without prior vitamin D 
testing 
No vitamin D test-
ing/screening; vitamin D 
supplementation without 
prior vitamin D testing 
No vitamin D supplemen-
tation (placebo or regular 
care) 
 HTA Scoping Report 20 
Outcomes Bone health-related 
outcomes 
Indirect bone health-re-
lated outcomes 
Non-bone health-re-
lated outcomes  
Costs, QALYs, HRQoL, 
life years gained, 
ICER/ICURs, net or gross 
budget impact 
Refer to Table 4 
Study designs 
 
HTA reports, SRs, 
Mendelian RCTs, MAs, 
RCTs, any other exper-
imental comparative 
study design and ob-
servational studies 
HTA reports, systematic 
reviews, economic evalu-
ations, economic evalua-
tions alongside clinical tri-
als (EEACTS), costing 
studies, budget impact 
studies 
Umbrella reviews (URs), 
HTA reports, SRs (includ-
ing Cochrane reviews), 
Meta-analysis (MAs) (in-
cluding network MAs/indi-
rect treatment compari-
sons)  
 
Key: HTA=health technology assessment, HRQoL = health related quality of life, ICER/ICUR=incremental cost-effectiveness ra-
tio/cost-utility ratio, MA=meta-analysis, QALYs=quality adjusted life years, RCT=randomized controlled trial, SR=systematic re-
view, UR=umbrella review, USA=United States of America 
* Caveat: Rickets, osteomalacia, osteoporosis, hyperparathyroidism and low trauma fracture need vitamin D testing for diagnostic 
reasons 
 
Table 4 describes the outcomes considered for the URQ, which were pre-selected by clinical experts. 
Table 4. Outcomes Considered in the Review of Clinical Evidence of Vitamin D Supplementation 
(URQ) 
Population:  
 
Outcomes considered not 
bone related  
Outcomes considered bone re-
lated  
• Persons with bone disor-
ders 
• Older adults (≥ 65yrs) 
• Obese individuals 
• Individuals with dark skin 
• Athletes 
• Physical Performance 
• Muscle strengths 
• Falls  
• Injury 
• Pain 
• Mortality (all-cause or 
cancer related) 
• Fractures (stratified; e.g. ver-
tebral, non-vertebral) 
• Bone Mineral Density 
• Pregnant and lactating 
women 
• Preeclampsia 
• Maternal gestational dia-
betes 
• Preterm births 
• Low birth weight 
• Fractures (stratified; e.g. ver-
tebral, non-vertebral) 
• Bone Mineral Density 
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7. Systematic Search Strategy 
7.1.  OutcomesA systematic literature search was conducted to extract the available evidence in-
vestigating clinical and economic effects of vitamin D testing in various groups at risk. A synthe-
sis of the evidence is presented. A summary and an analysis of the individual outcomes are the 
objective of a full HTA, if commissioned.   
Furthermore, a systematic literature search was conducted to extract the available evidence investigat-
ing which group(s) at risk profit from vitamin D supplementation in terms of improved bone-related or 
non-bone-related outcomes. In addition to extracting and synthesizing the evidence, the outcomes are 
summarized.    
The selected evidence for vitamin D testing (CRQ) and vitamin D supplementation (URQ) is presented 
in PRISMA flow diagrams in Chapter 8, summarized descriptively in Chapter 9 and presented in tables 
showing the characteristics and results of the studies in Chapter 13.  
 
7.2. Search Strategy and Procedure: Effectiveness 
Three systematic literature search strategies are followed to address CRQa and CRQb, as well as the 
URQ. 
Search Strategy 1: CRQa for clinical evidence of vitamin D testing 
Search Strategy 2: CQRb for economic evidence of vitamin D testing 
Search Strategy 3: URQ for clinical evidence of vitamin D supplementation 
 
Search Strategy 1: CRQa. The searches for clinical evidence for CRQa were performed on 15th January 
2019 using MEDLINE (OVID), EMBASE (OVID), Centre for Reviews and Dissemination (CRD) data-
base, the Cochrane Central Register of Controlled Trials (Cochrane CENTRAL) and Epistemonikos.  
Search Strategy 2: CQRb: The search for economic evidence for CRQb was performed on 4th January 
2019 using MEDLINE (OVID), EMBASE (OVID) and the Centre for Reviews and Dissemination (CRD) 
database. Details on keyword search strings and use of search filters are presented in Appendices 1-
3. 
Search Strategy 3: URQ: The searches for clinical evidence for URQ were performed on 15th January 
2019 using MEDLINE (OVID), EMBASE (OVID), Centre for Reviews and Dissemination (CRD) data-
base, the Cochrane Central Register of Controlled Trials (Cochrane CENTRAL) and Epistemonikos.  
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7.3. Inclusion and exclusion criteria 
Studies were included when they were published between January 2000 and January 2019. This was 
because two experts in the field of nutrition confirmed to us that literature on vitamin D supplementation 
representing the groups at high risk of severe vitamin D deficiency defined by the FCN only started 
being published from 2000 until December 2018. Only English language studies were considered (as 
most published scientific literature is in English); therefore, we may have missed relevant literature in 
other languages. Studies with vitamin D supplementation in combination with calcium were included. 
On the other hand, studies with bolus dose vitamin D supplementation (i.e. high dose intermittent vitamin 
D supplementation (>1 month)) were excluded. Also, other forms of vitamin D fortification as an inter-
vention were excluded. Differences between the three search strategies regarding different interven-
tions, outcomes and study types are described in Table 3. Although for CRQa and the URQ Cochrane 
CENTRAL and Epistemonikos were searched, these databases were not searched for the review of 
economic studies (CRQb). 
 
7.4. Screening and selection procedure 
A total of six reviewers conducted the 1st level screening of all titles and abstracts. A minimum of 5% of 
the literature was screened in duplicate, prior to single screening. Single screening was only started 
after confirmation of high agreement (>95%) between the pairs of reviewers. The full selection of titles 
and abstracts were screened with a focus on the FCN-defined at-risk groups described in Table 3. Titles 
and abstracts that are deemed appropriate from 1st level of screening as they demonstrated possibility 
of satisfying the PICOS criteria in Table 3, underwent full-text screening. Discrepancies between review-
ers were double screened by other members of the review team. Resulting articles were selected for 
data extraction. 
Only for Search Strategy 3: URQ (clinical evidence of vitamin D supplementation), an additional 
selection procedure was applied, given the large body of available evidence. Strict criteria were applied 
to select studies in a transparent and reproducible manner. The criteria include: 
• Only considering the outcomes paired to the relevant risk group (henceforth referred to as “out-
come-risk group pairs”; e.g. falls in older adults) listed in Table 4. 
• After full-text screening, all umbrella reviews (URs) which addressed a relevant outcome-risk 
group pair were included. URs specifically refer to reviews compiling evidence from multiple 
reviews into one accessible and useable document. URs focus on broad conditions or problems 
for which there are competing interventions. This is done by highlighting reviews that address 
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these interventions and their results 69. We classified as URs reports, which focus on identifying 
systematic reviews and synthesizing their results. 
• Only if no UR for an outcome-risk group pair was identified, we included all Cochrane reviews 
that were identified as addressing the outcome-risk group pair. 
• Only if no UR or Cochrane review for an outcome-risk group pair was identified, we included 
the most recent SR addressing the outcome-risk group pair. If the most recent SR was of a low 
quality rated by the Assessing Methodological Quality of Systematic Reviews (AMSTAR) check-
list 70, we additionally included the second most recent SR addressing the outcome-risk group 
pair if available.  
For the URQ only, we may have excluded some relevant studies assessing bone mineral density as an 
outcome during titles and abstracts screening. This is because we originally did not plan to include bone 
mineral density as an outcome for the URQ but only decided to do this after titles and abstracts screen-
ing.  
7.5. Search Strategy and Procedure legal, ethical, social and organizational issues 
The systematic literature search in this scoping report did not address evidence pertaining to legal, 
ethical, social and organizational issues related to the HTA topic. This search will be performed in the 
HTA report, if commissioned. 
 
8. Synthesis of Evidence Base 
8.1. PRISMA Flow Diagram 
PRISMA flow diagrams for the three search strategies are presented in this section in accordance with 
the PRISMA guidelines 71. 
 
8.1.1. Vitamin D Testing (Clinical; CRQa) 
The systematic literature search identified 4,641 studies of which 1,749 were duplicates. Titles and ab-
stracts screening resulted in 84 studies for full text screening. In the full text screening, 81 studies were 
excluded; the reasons for excluding these studies are presented in the PRISMA diagram in Figure 3 
and listed in Appendix 9. Three studies (one SR72 and two HTAs73 74) were included in the final review. 
The characteristics of the selected studies are presented in Appendix 4. The findings of the studies are 
described in Chapter 9. 
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Figure 3. PRISMA Diagram, Vitamin D Testing (Clinical; CRQa) 
 
 
Records identified through database searching 
(n = 4641) 
EMBASE n=1669, MEDLINE n=621, 
 CRD n=385, CENTRAL n= 451, 
 Epistemonikos n=1515 
Records after duplicates removed 
(n = 2892) 
Records screened 
(n =  2892) 
Records excluded 
(n = 2808) 
 
Full-text articles assessed for  
eligibility  
(n =84)  
Full-text articles excluded, with 
reasons, (n = 81) 
• Incorrect population (FCN 
group), n= 8 
• Incorrect setting, n=4 
• Incorrect intervention, n=30 
• Incorrect comparator, n=7 
• Incorrect outcomes, n=1 
• Incorrect study type, n=20 
• Incorrect study design, n=5 
• Language (non-English), n=3 
• E-pub ahead of print in private 
journal, unavailable access to 
University at present, n=3 
Studies included  
(n = 3) 
• HTAs, n=2 
• SRs, n=1 
• RCTs, n=0 
• Observational and cohort studies, n=0 
Duplicates removed 
(n=1749,  
1741 + 8 additional duplicates dur-
ing screening) 
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8.1.2. Vitamin D Testing (Economic, CRQb) 
The systematic literature search identified 921 studies of which 147 were duplicates. Titles and abstracts 
screening resulted in 16 studies for full text screening. In the full text screening, 13 studies were ex-
cluded; the reasons for excluding these studies are presented in the PRISMA diagram in Figure 4 and 
listed in Appendix 10. Three studies were included in the final review.  
Figure 4. PRISMA Diagram, Vitamin D Testing (Economic) 
  
Records identified through database searching 
(n = 921) 
EMBASE n=372, MEDLINE n=172, CRD n=377 
Records after duplicates removed 
(n = 774) 
Records screened 
(n =  774) 
Records excluded 
(n = 758) 
Full-text articles assessed for eligibility  
(n = 16) 
Full-text articles excluded, with rea-
sons, (n = 13) 
• Non-economic study, n= 5 
• HTA report that does not identify 
any economic analysis in addition 
to the three that we included, n= 2 
• Incorrect PICOS, n =6 
Studies included  
(n = 3) 
• Costing studies, n=1 
• Cost-effectiveness analyses, n=2 
Duplicates removed 
(n = 147) 
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The literature search identified three economic analyses 24 75 76. Characteristics of the selected studies 
are tabulated in Appendix 5 and results in Appendix 6. Findings are described in Chapter 9.  
 
8.1.3. Vitamin D Supplementation (URQ) 
The systematic literature search identified 6,525 studies of which 2,480 were duplicates. Titles and ab-
stracts screening resulted in 835 studies for full text screening. In the full text screening, 813 were ex-
cluded; the reasons for excluding these studies are presented in the PRISMA diagram in Figure 5 and 
listed in Appendix 11. 21 studies were included in the final review. Characteristics of the selected stud-
ies are tabulated in Appendix 7 and results in Appendix 8. 
We used the AMSTAR checklist only for the URQ, to assess the quality of the URs and SRs identified 
from the URQ systematic literature search. We agreed to use the following AMSTAR scoring classifica-
tion specified by the Canadian Agency for Drugs and Technologies in Health (CADTH): low quality re-
view (score 0 to 3), medium quality (score 4 to 7), and high quality (score 8 to 11) 70. Quality of the 
reviews was generally assessed as high for pregnant women (median AMSTAR score of 11), medium 
for older adults (median AMSTAR score of 6), athletes (median AMSTAR score of 6) and persons with 
bone disorders (median AMSTAR score of 5), and low for obese individuals (median AMSTAR score of 
2). AMSTAR scores assessed for each individual review that we included for the URQ, are presented 
in Appendix 8.  
Our study selection procedure meant that we focused on umbrella reviews for the majority of outcomes, 
and only included systematic reviews where an umbrella review was not identified. Such a procedure 
may mean that we excluded recently published systematic reviews of relevance. In comparison with a 
full-scale, much more resource-intensive systematic review approach, a certain risk of bias is implied. 
Furthermore, some umbrella or systematic reviews could be classified into both the bone disorders and 
in the older adults groups. In these cases, we assigned the review to the bone disorders group if the 
authors stated a focus of their review was on persons with a bone disorder or especially high risk of 
having a bone disorder, and otherwise assigned the review to the older adults group. Furthermore, we 
classed Bolland et al (2018) as an UR 77. Although they looked at individual trials, they also synthesized 
previously published meta-analyses. For data extraction of Bolland et al (2018) 77, we only extracted the 
results of the subgroup analyses focused on daily vitamin D supplementation (and therefore excluded 
trials of bolus vitamin D supplementation). The methodological quality of the review by Bolland et al has 
been questioned 78. Bolland et al excluded all trials that compared combined vitamin D and calcium 
supplementation, with placebo.  
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Figure 5. PRISMA Diagram, Vitamin D Supplementation 
 
 
   
Records identified through database 
searching 
(n = 6525) 
EMBASE n=2943, MEDLINE n=1671 
 CRD n=398, Epistemonikos n=1513 
 
Records after duplicates removed 
(n = 4045) 
 
Records screened 
(n =  4045) 
Records excluded 
(n =3210) 
Full-text articles assessed for eligibility  
(n = 835) 
Studies included  
 
(n= 21) 
Duplicates removed 
(n = 2480) 
Full-text articles excluded, with reasons      
(n = 814) 
• Incorrect population/FCN at risk group, 
n=167 
• Incorrect setting, n=28 
• Incorrect intervention, n=86 
• Incorrect comparator, n=23 
• Incorrect outcomes, n=115 
• Incorrect study type, n=187 
• Prioritised UR/CR/more recent SR in-
stead, n=92 
• Duplicate record, n=17 
• 100% overlap with other UR, n=2 
• Other: n=97 (e.g. incorrect study de-
sign, general population studies) 
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9. Findings  
9.1.   Findings of Vitamin D Testing 
9.1.1. Clinical effectiveness of vitamin D testing (CRQa) 
Three studies were identified, which were published between 2012 and 2015. The three studies included 
one SR (LeBlanc et al (2015) 72), two HTA reports (CADTH 2014a 73, CADTH 2014b 74) and zero em-
pirical studies. LeBlanc et al (2015) conducted a systematic search for randomized trials of the clinical 
effectiveness of vitamin D testing versus no testing, and found zero randomized trials evaluating this 72. 
CADTH (2014a) conducted a systematic search for empirical studies of the clinical effectiveness of 
vitamin D testing in northern populations, and found zero empirical studies evaluating this 73. CADTH 
(2014b) conducted a systematic search for empirical studies of the clinical effectiveness of vitamin D 
testing in the general population, and found one empirical study evaluating this, but the study had a 
retrospective design thus was not eligible for our report 74. 
In summary, we could not identify any randomized trial-based evidence on vitamin D testing. 
 
   9.1.2.   Costs and cost-effectiveness of vitamin D testing (CRQb) 
We identified one costing study and two cost-effectiveness studies of vitamin D testing; findings are 
summarized below and described and tabulated in Appendix 6.  
Costs and budget impact 
A HTA published in 2015, reported a UK costing and budget impact study conducted by the York Health 
Economics Consortium (YHEC) for a submission to NICE (National Institute of Health and Care Excel-
lence) 24. The target populations (aligned with groups at high risk of severe vitamin D deficiency as 
defined by the FCN) were older people (aged 65 and over) and people with darker skin. Assessed were 
costs and budget impact of vitamin D testing in risk groups and subsequent daily 3000 IU vitamin D 
supplementation for those deficient (vitamin D testing and treatment strategy for the deficient), and vit-
amin D supplementation of daily 1000 IU without prior vitamin D testing within each risk group (no vita-
min D testing and supplementation strategy for all). For older people as well as for people with darker 
skin, overall costs were estimated to be lower if supplementation of vitamin D without prior vitamin D 
testing was given instead of implementing the vitamin D testing and treatment strategy.  
Vitamin D testing all UK persons aged 65 or above (population size of 9,176,882 of which 11% were 
assumed in the study to be vitamin D deficient), was estimated to result in higher (incremental) costs of 
GBP 25,359,122 relative to providing vitamin D supplementation without prior vitamin D testing for these 
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people. Vitamin D testing all UK persons with dark skin (population size of 15,733,034 of which 69% 
were assumed in the study to be vitamin D deficient), was estimated to result in higher (incremental) 
costs of GBP 160,181,034 relative to providing vitamin D supplementation without prior vitamin D testing 
for these people.  
Cost-effectiveness 
A USA economic evaluation by Lee et al in 2012 assessed the cost-effectiveness of selective vitamin D 
supplementation following a vitamin D test, versus vitamin D supplementation without prior vitamin D 
testing, or no vitamin D supplementation, in older women and men (65-80) 75. Effectiveness estimates 
were based on a MA of vitamin D supplementation (rather than vitamin D testing) showing that vitamin 
D supplementation reduces the risk of falls, although Lee et al did not precisely state which MA they 
used to parameterize the economic model. Costs and quality-adjusted life years (QALY) were evaluated 
over a 3-year period. A willingness-to-pay threshold of USD 50,000 per QALY gained was used. For 
females aged 65-80 years the vitamin D testing and supplementation strategy was 52.8% likely to be 
the most cost-effective strategy (as 52.8% of simulations in the probabilistic sensitivity analysis indicated 
the highest net monetary benefit was for this strategy), compared to 36.3% probability for the vitamin D 
supplementation without prior vitamin D testing strategy. Using the same threshold for males aged 65-
80 years, vitamin D testing and supplementation was 54.3% likely to be the most cost-effective strategy 
compared to just 38.2% probability for the vitamin D supplementation without prior vitamin D testing 
strategy. The authors did not estimate incremental cost-effectiveness ratios (ICERs). 
The French economic evaluation by Zarca et al in 2014 76 assessed the cost-effectiveness of:  
i) vitamin D testing all older adults aged ≥ 65 years without previous hip fracture followed by vitamin D 
supplementation of those measured as vitamin D deficient 
and ii) vitamin D supplementation of all older adults without previous hip fracture followed by a test three 
months after initiation and subsequent treatment adaptation for older adults aged ≥ 65 years without a 
previous hip fracture.  
Effectiveness estimates were based on two MAs of vitamin D supplementation (rather than vitamin D 
testing), which indicated vitamin D supplementation reduces hip fracture risk 79 80. Costs and QALYs 
were evaluated over the lifetime of the individuals. It was found that for a willingness-to-pay threshold 
of over EUR 6,000 per QALY, the strategy of vitamin D testing all older adults without previous hip 
fracture followed by vitamin D supplementation of those measured as vitamin D deficient (strategy (i)) 
was the most likely strategy to be cost-effective. Strategy (i) produced an ICER of €5,219 per QALY 
compared to no vitamin D supplementation. 
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In summary, economic results for testing in older adults were mixed and non-conclusive. For older 
adults as well as for people with darker skin, overall costs were estimated to be lower if supplementation 
of vitamin D without prior vitamin D testing is given, in comparison with a strategy of vitamin D testing 
and treatment for the deficient.  
Conversely, both cost-effectiveness studies that we identified reported that initial vitamin D testing in 
older adults and subsequent supplementation for the deficient was more cost-effective than initial vita-
min D supplementation for all older adults. Both these cost-effectiveness studies based their effect es-
timates on meta-analyses which indicated vitamin D supplementation is effective at improving falls and 
fracture outcomes. 
    
9.2.  Findings of Vitamin D Supplementation (URQ) 
Study findings in a tabulated format are presented in Appendix 8. 
9.2.1. Descriptive Presentation 
Table 4 refers to more outcomes than are reported in this section, as there were no SRs for some 
outcomes. For persons with bone disorders, we only identified reviews addressing fracture and BMD 
outcomes. For obese individuals, we only identified reviews addressing BMD outcomes. For athletes, 
we only identified reviews addressing injury, physical performance and muscle strength outcomes. For 
persons with dark skin, we did not identify any reviews addressing the outcomes listed in Table 4. 
 
FCN Group 1: Persons with Bone Disorders 
This section describes the results of the reviews focusing on older adults who have a bone disorder or 
especially high risk of acquiring one. The studies identified included populations with high fracture risk, 
low BMD/osteoporosis and previous hip fracture. The effects of vitamin D supplementation may differ in 
such persons compared to general populations of older adults. URs/SRs focusing on patients with a 
pre-existing history of osteomalacia or rickets were not identified. We found fewer studies on vitamin D 
supplementation in older adults with bone disorders, and they involved smaller sample sizes than stud-
ies in general populations of older adults. 
Fractures (people with high fracture risk). An UR by Maclean et al (2008) 81 assessed effects of 
vitamin D supplementation relative to placebo on the fracture risk in people with a high risk of fracture 
(e.g. 50% of trial participants with previous osteoporotic fracture at baseline). In the UR, two SRs were 
identified for vertebral fracture published by Avenell et al (2005) 82 and Stevenson et al (2005) 83. They 
involved 2745 and 109 participants in the pooled analyses, respectively. Both reported no significant 
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effects for vertebral fracture (RR of vitamin D supplementation versus placebo=3.97 (95% CI: 0.44 to 
35.45) in Avenell et al (2005); RR of vitamin D supplementation versus placebo=1.02 (95% CI: 0.44 to 
2.32)) in Stevenson et al (2005)). In the UR, one SR was identified for non-vertebral fracture published 
by Stevenson et al in 2005 83 (213 participants), which reported no significant effect (RR not numerically 
reported but depicted as non-significant in forest plot). In the UR, one SR was identified for hip fracture 
(updated in 2014 by Avenell et al with 2820 participants 84), which reported no significant effect (RR of 
vitamin D supplementation versus placebo=1.08 (95% CI: 0.72 to 1.62)) in 2014 update.  
Fractures (people with low bone density or osteoporosis). A SR by Qaseem et al (2017) 85 evalu-
ated 68 studies on vitamin D supplementation alone (without calcium) in persons with low bone density 
or osteoporosis, and assessed that the effect on fracture risk was uncertain due to mixed findings across 
MAs/RCTs; the authors evaluated the quality of the studies to be of a moderate quality from GRADE 
assessment.  
Second fracture (persons after first hip fracture). A SR by Egan et al (2008) identified one relevant 
RCT including 76 participants of the effect of vitamin D plus calcium supplementation on the risk of 
second hip fracture in persons recovering from their first hip fracture 86. Over 12 months, 8% (n=3) of 
the vitamin D plus calcium group experienced a second fracture; whereas 14% (n=5) of placebo group 
experienced a second fracture. Due to the small sample size, the statistical significance of this difference 
between groups was not assessed.  
Bone mineral density (female elderly nursing home residents). A SR by Parikh et al (2009) 87 iden-
tified three relevant RCTs on the effect of vitamin D supplementation on BMD in nursing home residents. 
All three RCTs comprised of female nursing home residents aged at least 79 years; thus the majority 
were likely to have osteoporosis. All three RCTs found that vitamin D plus calcium supplementation was 
associated with higher BMD outcomes after 18 to 24 months; however, confidence intervals were not 
reported.  
 
In summary, the evidence of effectiveness of vitamin D supplementation was generally mixed and 
sparse for persons with a bone disorder. 
 
FCN Group 2: Older Adults 
Falls. A total of three URs were identified assessing the effect of vitamin D supplementation alone on 
falls (Stubbs et al (2015a), Medical Advisory (2008) and Poscia et al (2018)). Stubbs et al (2015a) 88 
and Medical Advisory (2008) 89 indicated no effect on falls resulting from vitamin D supplementation 
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alone. However, Poscia et al (2018) 90, reported a reduction in falls in three of the SRs that they identi-
fied. Three URs were identified which assessed vitamin D co-administered with calcium (Stubbs et al 
(2015a) 88, Poscia et al (2018) 90 and Medical Advisory (2008) 89), all three indicated a resultant reduction 
in falls, although Medical Advisory (2008) found this reduction was evident for women only (RR=0.83 
(95% CI: 0.73 to 0.95); 2,121 women from two trials)89. Four URs 77 91-93 were identified, which assessed 
mixed studies of vitamin D either alone or with calcium. Of these one UR 77 reported a statistically sig-
nificant reduction in falls from daily vitamin D supplementation with or without calcium (Bolland et al 
(2018) subgroup results, RR=0.92, 95% CI: 0.87 to 0.98). Another UR also indicated a reduction in falls 
from vitamin D supplementation with or without calcium (Scragg et al (2012)) 91, but the other two URs 
indicated no effect on falls from vitamin D with or without calcium (Theodoratou et al (2014) 92 and 
Stubbs et al (2015b) 93). Only one UR on the effect of vitamin D supplementation with calcium on fall-
related fractures or fall-related injuries was identified, which was published by Medical Advisory in 2008 
89. This UR reported a non-significant reduction in fall-related fractures (RR=0.77 (95% CI: 0.49 to 1.21), 
two studies of vitamin D and calcium, 3,980 participants) and fall-related injuries (RR=0.48 (95% CI: 
0.12 to 1.84), one study, 148 women). 
Fractures. Out of the two URs assessing vitamin D supplementation alone (Vestergaard et al (2011) 94 
and Poscia et al (2018) 90), both indicated no effect on fractures (either vertebral or non-vertebral). Out 
of the two URs identified assessing vitamin D co-administered with calcium (Vestergaard et al (2011)94 
and Poscia et al (2018)90), both indicated a reduction in fractures from supplementation, although 
Vestergaard et al 94 indicated that this reduction was evident for non-vertebral but not for vertebral frac-
ture, both based on low-quality evidence. Out of the three URs identified assessing mixed studies of 
vitamin D supplementation either alone or with calcium, two indicated no effect on fractures (Theodora-
tou et al (2014) 92 and Bolland et al (2018) subgroup results) 77, although the third UR (Scragg et al 
(2012)) 91 indicated a reduction in some types of fractures. 
Muscle strength. Two URs for muscle strength outcomes in older adults were identified published in 
2018 and 2014, respectively. The 2018 UR was published by De Spiegeleer et al 95, and identified two 
SRs by Anagnostis et al (2015) and Beaudart et al (2017). Evidence of improvement in muscle strength 
from vitamin D supplementation in women was observed in the review by Anagnostis et al 96, but in the 
review by Beaudart et al 97, no effect of vitamin D supplementation was found. The 2014 UR by Theo-
doratou et al 92 identified one MA comprising three RCTs that found non-significant improvement in 
lower extremity muscle strength from vitamin D supplementation (standardised mean difference=0.05 
(95% CI: -0.11 to 0.20)).  
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Physical performance. Two URs for physical performance outcomes from vitamin D supplementation 
in older adults published in 2018 and 2014, were identified. The 2018 UR was published by De Spie-
geleer et al 95 and identified two reviews (one UR and one SR); with the first review finding improvement 
in the timed-up-and-go test from vitamin D supplementation in 50% of included RCTs, and the second 
review reporting no improvement in gait based on studies of limited methodological quality. The 2014 
UR was published by Theodoratou et al 92 and identified one MA comprising three RCTs that observed 
improvement (i.e. reduction) in the balance sway from vitamin D supplementation (standardised mean 
difference=-0.20 (95% CI: -0.39 to -0.01)). 
Bone mineral density. Unlike the other outcomes in this section, which were based on a systematic 
search, we carried out a non-systematic search to identify SRs evaluating BMD. For older adults, one 
UR for a BMD outcome was identified which was published by Bolland et al in 2018 (subgroup results) 
77. In this UR, a subgroup meta-analysis of daily vitamin D supplementation was carried out by the 
authors, in which data was pooled from 18 RCTs. In the subgroup analysis, no statistically significant 
improvement in lumbar spine BMD from daily vitamin D supplementation was observed (weighted mean 
percentage difference=0.15% (95% CI: -0.13 to 0.44)).  
All-cause mortality. The most recent UR we identified for all-cause mortality was from Poscia et al 
(2018) 90. The UR concluded that vitamin D supplementation did not have a significant effect on all-
cause mortality in a population of post-menopausal women and older men (for vitamin D supplementa-
tion alone compared with no vitamin D supplementation, RR=0.99 (95% CI: 0.94 to 1.03): for vitamin D 
co-administered with calcium supplementation compared with no vitamin D supplementation, RR=0.94 
(95% CI: 0.87 to 1.02)). However, an UR by Scragg et al (2012) 91 identified two SRs which both indi-
cated no statistically significant reduction in mortality when vitamin D is administered alone but a statis-
tically significant reduction in mortality from supplementation when vitamin D is co-administered with 
calcium to people aged ≥ 60 years. 
Cancer-related mortality. A Cochrane review by Bjelakovic et al (2014) 98 identified and pooled the 
results of four RCTs that included 44,492 participants in total, to assess the effect of vitamin D supple-
mentation on cancer-related mortality in postmenopausal women and older men. The authors found 
that, based on moderate quality evidence, vitamin D3 statistically significantly decreased cancer mor-
tality (RR=0.88 (95% CI: 0.78 to 0.98). 
Pain. A SR by Husebo et al (2016)99 on the effect of vitamin D supplementation on pain in persons with 
dementia identified one relevant RCT, which found no significant effect of Vitamin D3 supplementation 
(p>0.10 for all pain measures administered to persons with advanced dementia). 
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Findings for subpopulations of older adults 
Stakeholders made us aware of the following three studies: Cameron et al (2018) 100, Tricco et al (2017) 
101  and Zhang et al (2019) 102, which however were not eligible for inclusion according to our pre-defined 
selection criteria. We report these analyses due to concerns that effects may be stronger or better visible 
in some subpopulations of older adults. These studies include participants with mean age of ≥ 65 years 
for the main analysis. 
A Cochrane review published by Cameron et al in 2018 100 found, in a subgroup of participants in care 
facilities and hospitals, that vitamin D supplementation reduced the rate of falls (rate ratio=0.72 (95% 
CI: 0.55 to 0.95), 4,512 participants) but not the risk of falls (RR= 0.92 (95% CI: 0.76 to 1.12), 4,512 
participants) or the risk of fractures (RR=1.09 (95% CI: 0.58 to 2.03), 4,464 participants). 
A network meta-analysis published by Tricco et al in 2017 101 found, in a subgroup of participants re-
ceiving vitamin D and calcium supplementation combined with clinic-level quality improvement strate-
gies (e.g., case management) and multifactorial assessment and treatment (e.g., comprehensive geri-
atric assessment), that the study intervention reduced the risk of injurious falls (odds ratio=0.12 (95% 
CI: 0.03 to 0.55; 41,596 participants). 
A systematic review published by Zhang et al in 2019 102 found, in subgroups supplemented with differ-
ent modes of vitamin D, that both, vitamin D2 (RR=1.03 (95% CI: 0.98 to 1.09), 17,544 participants), 
and vitamin D3 (RR=0.95 (95% CI: 0.90 to 1.00), 57,910 participants) did not reduce all-cause mortality. 
However, the authors reported that all-cause mortality was significantly lower in trials with vitamin D3 
supplementation than in trials with vitamin D2 supplementation (P for interaction=0.04).  
 
In summary, the evidence of effectiveness of vitamin D supplementation was generally mixed for older 
adults. 
    
FCN Group 3: Obese Individuals 
Bone mineral density (BMD). Unlike the other outcomes in this review, which were based on a sys-
tematic search, we carried out a non-systematic search in July 2019 to identify SRs evaluating BMD. 
For obese individuals, a SR from Bassatne et al (2019) 103 performed a search from 2010 to 2018 and 
identified one RCT assessing the effect of vitamin D supplementation on BMD in obese individuals. The 
RCT administered vitamin D3, and observed no significant differences between groups regarding 
change in BMD.  
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In summary, the evidence of effectiveness of vitamin D supplementation was generally sparse for 
obese individuals. 
    
FCN Group 4: Pregnant Women 
Pre-eclampsia. An UR by Browne et al (2016) 104 identified one SR assessing pregnancy-related out-
comes (e.g. pre-eclampsia, low birthweight, maternal gestational diabetes, preterm birth) from vitamin 
D supplementation in pregnant women. The SR was updated in 2019 by Palacios et al 105. Both the 
original systematic review and its update in 2019, found zero RCTs on the effect of vitamin D supple-
mentation on pre-eclampsia in a Western country.     
Low birthweight. An UR by Browne et al (2016) 104 identified one SR assessing pregnancy-related 
outcomes from vitamin D supplementation in pregnant women. The SR was updated in 2019 by Palacios 
et al 105, and the combined searches found one Western country trial on the effect of vitamin D supple-
mentation on low birthweight, which reported no statistically significant effect (RR for vitamin D mono-
therapy relative to no intervention was 0.53 (95% CI: 0.23 to 1.21) based on a sample of 126 women). 
Maternal gestational diabetes. An UR by Browne et al (2016) 104 identified one SR assessing preg-
nancy-related outcomes from vitamin D supplementation in pregnant women. The SR was updated in 
2019 by Palacios et al 105. Both the original systematic review and its update in 2019, found zero trials 
on the effect of vitamin D supplementation on maternal gestational diabetes in a Western country. 
Preterm birth. An UR by Browne et al (2016) 104 identified one SR assessing pregnancy-related out-
comes from vitamin D supplementation in pregnant women. The SR was updated in 2019 by Palacios 
et al 105, and pooled the results of seven trials across developed and developing countries on the effect 
of vitamin D supplementation on preterm birth (< 37 weeks). The SR found the RR of a preterm birth of 
vitamin D monotherapy relative to no intervention was 0.66 (95% CI 0.34 to 1.30), and concluded that 
vitamin D monotherapy supplementation may make little or no difference in the risk of having a preterm 
birth based on low‐certainty evidence.  
Offspring bone mineral content (BMC). Unlike the other outcomes in this review, which were based 
on a systematic search, we carried out a non-systematic search to identify SRs evaluating BMC. For 
the offspring of pregnant women, a 2014 SR by Harvey et al 106 identified one RCT assessing the effect 
of vitamin D supplementation in pregnant women on offspring bone mineral content. There was no sig-
nificant difference in the BMC of the forearms of babies born to these women between the intervention 
and comparator groups (mean bone mass outcome of 3.19 units at birth in the vitamin D and calcium 
group, 3.10 units at birth in the “no intervention” group; no p value reported). The SR also evaluated that 
the RCT had a high risk of bias.  
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Maternal bone mineral density. Unlike the other outcomes in this review, which were based on a 
systematic search, we carried out a non-systematic search to identify SRs evaluating BMD. For pregnant 
women, a SR by Cranney et al (2007) 33 was identified, and found zero trials on the effect of vitamin D 
supplementation in pregnant women on maternal bone mineral density.  
Maternal fractures. We found one SR on the  effect of vitamin D supplementation in pregnant women 
on maternal fractures, which was published by Cranney et al in 2007 33, and identified zero trials. 
 
In summary, the evidence of effectiveness of vitamin D supplementation was generally sparse for preg-
nant women. 
    
FCN Group 5: Children and Adults with a Dark Skin Tone 
No appropriate SR was found, but a future SR for which the protocol has been published (Cashman et 
al (2019)) 107 may be of relevance. 
    
FCN Group 6: Athletes 
Injury. We identified a SR by Farrokhyar et al (2017) 108, which found no RCTs evaluating the effect of 
vitamin D supplementation on injury in athletes.  
Physical performance. We identified a SR by Farrokhyar et al (2017) 108, which found seven RCTs 
evaluating the effect of vitamin D supplementation on physical performance outcomes in athletes. The 
SR found no significant improvement in physical performance from vitamin D supplementation, as no 
significant between-groups differences were found in vertical jump height (0.92 cm (95% CI:-0.55 to 
2.44)), one repetition maximum (1-RM) bench press (2.05 (95% CI:-5.5 to 9.6)) or 10- to 30meters sprint 
(0.04 s (95% CI:-0.04 to 0.12)). 
Muscle strength. We identified a SR published by Chiang et al (2017) 109 (rated low quality by AM-
STAR), which found four trials evaluating the effect of vitamin D3 supplementation and two trials evalu-
ating the effect of vitamin D2 supplementation on muscle strength. In the SR, vitamin D3 was shown to 
result in an improvement in muscle strength (p≤ 0.05 in two trials; non-significant improvements in mus-
cle strength in the other two trials). Vitamin D2 was found to be ineffective at impacting muscle strength 
in both trials (p>0.05 in each of the two trials).  
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In summary, the evidence of effectiveness of vitamin D supplementation was generally mixed/sparse 
for athletes.    
10. Feasibility of HTA and Conclusions 
The focus of the present report was to identify studies, which have assessed the effect of vitamin D 
testing on clinical outcomes in selected FCN-defined risk groups, rather than to explore the mechanisms 
by which vitamin D testing may improve clinical outcomes.  
In the systematic literature search, we found a lack of clinical evidence for vitamin D testing for persons 
with bone disorders, older adults, obese individuals, pregnant women, people with dark skin, and ath-
letes, as we identified three reviews but no primary studies. Also, the study situation regarding the cost-
effectiveness of vitamin D tests is limited. Therefore, conducting a full HTA on vitamin D testing could 
not be expected to yield additional, meaningful results.  
In populations who are likely to have low vitamin D status, vitamin D testing may be helpful in promoting 
adherence to prescribed supplementation, and informing the correct vitamin D dosage. A vitamin D test 
is useful and necessary for risk groups if a differentiated vitamin D supplementation with individual sat-
uration according to a pre-existing level of vitamin D deficiency is aimed for 110. However, no definitive 
conclusions can be drawn about the effectiveness of vitamin D testing since no trials have been con-
ducted to directly assess the impact of vitamin D testing on health outcomes (a previous HTA from the 
Washington State Health Care Authority in the USA in 2012 also came to this conclusion 49).  
Economic results for testing in older adults were mixed and non-conclusive.  
In regards to vitamin D supplementation, we pursued a systematic but non-comprehensive approach to 
the literature search and selection, which carries a potential risk of bias. On this basis, the evidence on 
effectiveness of vitamin D supplementation was generally mixed and not conclusive. 
We conclude that there is not sufficient evidence that would support the utility to test vitamin D in persons 
with bone disorders, older adults, obese individuals, pregnant women, people with dark skin, and ath-
letes.  
Vitamin D testing is recommended for patients where it is medically necessary, and this is not disputed 
in the present report. The lack of available evidence for vitamin D testing for defined at-risk groups from 
our review, could be informative in guiding a decision policy on vitamin D testing. 
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11. Outlook 
The scoping report aims to map the existing literature in the field of interest in terms of the volume, 
nature, and characteristics of the primary research. The scoping report of a body of literature is used to 
analyse the complexity and/or heterogeneity of the topic. Based on the scoping report the feasibility to 
produce a full HTA has been estimated. A full HTA on vitamin D testing cannot be justified at present 
due to the absence of clinical studies evaluating the effectiveness of vitamin D testing. Only after such 
studies have become available can the topic be re-considered. 
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13. Appendices 
Appendix 1. Keyword Search Strings - Clinical Effectiveness of Vitamin D Testing 
EMBASE Search Strategy- Clinical Effectiveness of Vitamin D Testing  
Database(s): Embase 1974 to 2019 January 18 
Search Strategy: 
 
# Searches Results 
1 exp screening/ or screening.mp. or testing.mp. or haemotologic 
test*.mp. or hemotologic test*.mp. or haemotological test*.mp. or 
hemotological test*.mp. or haemotology test*.mp. or hemotology 
test*.mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, key-
word, floating subheading word, candidate term word] 
1628248 
2 Clinical Trial/ 953685 
3 Randomized Controlled Trial/ 531886 
4 controlled clinical trial/ 459983 
5 multicenter study/ 204931 
6 Phase 3 clinical trial/ 37466 
7 Phase 4 clinical trial/ 3248 
8 exp RANDOMIZATION/ 81027 
9 Single Blind Procedure/ 33669 
10 Double Blind Procedure/ 157181 
11 Crossover Procedure/ 57925 
12 PLACEBO/ 329135 
13 randomi?ed controlled trial$.tw. 194930 
14 rct.tw. 30994 
15 (random$ adj2 allocat$).tw. 38801 
16 single blind$.tw. 22236 
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17 double blind$.tw. 194300 
18 ((treble or triple) adj blind$).tw. 904 
19 placebo$.tw. 283766 
20 Prospective Study/ 496222 
21 or/2-20 2076628 
22 Case Study/ 58701 
23 case report.tw. 372301 
24 abstract report/ or letter/ 1091920 
25 Conference proceeding.pt. 0 
26 Conference abstract.pt. 3260356 
27 Editorial.pt. 594275 
28 Letter.pt. 1054905 
29 Note.pt. 741015 
30 or/22-29 6065154 
31 21 not 30 1582846 
32 ("vitamin D" or cholecalciferol or ergocalciferol or calciferol or "vitamin 
D2" or "vitamin D3" or "hydroxyvitamin D" or vitamin-d or vitamin-d2 or 
vitamin-d3 or "25 hydroxyvitamin D" or "25 hydroxyvitamin D2" or "25 
hydroxyvitamin D3" or "25-hydroxyvitamin D" or "25-hydroxy-vitamin 
D" or "25-hydroxy-vitamin D2" or "25-hydroxy-vitamin D3" or 25OHD 
or "25-OH-vitamin D" or 25-OHD or calcidiol or calcifediol or dihydrota-
cysterol or alfacalcidol or calcitriol or colecalciferol).tw. or exp vitamin 
D/ 
144502 
33 exp cohort analysis/ or exp longitudinal study/ or exp prospective study/ 942069 
34 research subjects/ or exp "clinical trial (topic)"/ or (research or trial? or 
study or studies or pilot or program$ or longitudinal or prospective or 
retrospective).ti. or observational study as Topic/ 
2955073 
35 exp Meta Analysis/ 156343 
36 ((meta adj analy$) or metaanalys$).tw. 185093 
37 (systematic adj (review$1 or overview$1)).tw. 166158 
38 or/35-37 317284 
39 cancerlit.ab. 725 
40 cochrane.ab. 87227 
41 embase.ab. 91334 
42 (psychlit or psyclit).ab. 992 
43 (psychinfo or psycinfo).ab. 24313 
44 (cinahl or cinhal).ab. 26711 
 HTA Scoping Report 47 
45 science citation index.ab. 3344 
46 bids.ab. 613 
47 or/39-46 142964 
48 reference lists.ab. 17505 
49 bibliograph$.ab. 20726 
50 hand-search$.ab. 7449 
51 manual search$.ab. 4696 
52 relevant journals.ab. 1314 
53 or/48-52 46544 
54 data extraction.ab. 21486 
55 selection criteria.ab. 34153 
56 54 or 55 53509 
57 review.pt. 2398100 
58 56 and 57 26635 
59 letter.pt. 1054905 
60 editorial.pt. 594275 
61 animal/ 1399005 
62 human/ 19123958 
63 61 not (61 and 62) 1025168 
64 or/59-60,63 2657877 
65 38 or 47 or 53 or 58 377222 
66 65 not 64 367018 
67 1 and 32 7700 
68 31 or 33 or 34 or 65 4581908 
69 67 and 68 2278 
70 limit 69 to human 2159 
71 limit 70 to conference abstract status 490 
72 70 not 71 1669 
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MEDLINE Search Strategy- Clinical Effectiveness of Vitamin D Testing 
Database(s): Ovid MEDLINE(R) ALL 1946 to January 18, 2019 
Search Strategy: 
 
# Searches Results 
1 exp mass screening/ or screening.mp. or testing.mp. or haemotologic 
test*.mp. or hemotologic test*.mp. or haemotological test*.mp. or 
hemotological test*.mp. or haemotology test*.mp. or hemotology 
test*.mp. 
1085310 
2 Randomized Controlled Trials as Topic/ 120603 
3 randomized controlled trial/ 475004 
4 Random Allocation/ 97330 
5 Double Blind Method/ 149175 
6 Single Blind Method/ 26156 
7 clinical trial/ 514246 
8 clinical trial, phase i.pt. 18582 
9 clinical trial, phase ii.pt. 29985 
10 clinical trial, phase iii.pt. 14550 
11 clinical trial, phase iv.pt. 1642 
12 controlled clinical trial.pt. 92881 
13 randomized controlled trial.pt. 475004 
14 multicenter study.pt. 244189 
15 clinical trial.pt. 514246 
16 exp Clinical Trials as topic/ 321032 
17 or/2-16 1272839 
18 (clinical adj trial$).tw. 324113 
19 ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw. 161257 
20 PLACEBOS/ 34199 
21 placebo$.tw. 201220 
22 randomly allocated.tw. 25565 
23 (allocated adj2 random$).tw. 28680 
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24 or/18-23 577017 
25 17 or 24 1508653 
26 case report.tw. 282502 
27 letter/ 1013404 
28 historical article/ 349695 
29 or/26-28 1630943 
30 25 not 29 1474498 
31 ("vitamin D" or cholecalciferol or ergocalciferol or calciferol or "vitamin 
D2" or "vitamin D3" or "hydroxyvitamin D" or vitamin-d or vitamin-d2 or 
vitamin-d3 or "25 hydroxyvitamin D" or "25 hydroxyvitamin D2" or "25 
hydroxyvitamin D3" or "25-hydroxyvitamin D" or "25-hydroxy-vitamin D" 
or "25-hydroxy-vitamin D2" or "25-hydroxy-vitamin D3" or 25OHD or "25-
OH-vitamin D" or 25-OHD or calcidiol or calcifediol or dihydrotacysterol 
or alfacalcidol or calcitriol or colecalciferol).tw. or exp vitamin D/ 
81001 
32 exp Cohort Studies/ and cohort.ti,ab. 257643 
33 research subjects/ or exp clinical trials as topic/ or (research or trial? or 
study or studies or pilot or program$ or longitudinal or prospective or 
retrospective).ti. or observational study as Topic/ 
2572122 
34 (Meta-Analysis as Topic/ or meta analy$.tw. or metaanaly$.tw. or Meta-
Analysis/ or (systematic adj (review$1 or overview$1)).tw. or exp Review 
Literature as Topic/ or cochrane.ab. or embase.ab. or (psychlit or 
psyclit).ab. or (psychinfo or psycinfo).ab. or (cinahl or cinhal).ab. or sci-
ence citation index.ab. or bids.ab. or cancerlit.ab. or reference list$.ab. 
or bibliograph$.ab. or hand-search$.ab. or relevant journals.ab. or man-
ual search$.ab. or ((selection criteria or data extraction).ab. and review/)) 
not (comment/ or letter/ or editorial/) 
289323 
35 1 and 31 2884 
36 30 or 32 or 33 or 34 3739182 
37 35 and 36 756 
38 limit 37 to humans 621 
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CRD Search Strategy: Clinical Effectiveness of Vitamin D Testing 
CRD 
Results for: (vitamin D or cholecalciferol or ergocalciferol or calciferol or vitamin D2 or vitamin D3 or 
hydroxyvitamin D or vitamin-d or vitamin-d2 or vitamin-d3 or 25 hydroxyvitamin D or 25 hydroxyvita-
min D2 or 25 hydroxyvitamin D3 or 25-hydroxyvitamin D or 25-hydroxy-vitamin D or 25-hydroxy-vita-
min D2 or 25-hydroxy-vitamin D3 or 25OHD or 25-OH-vitamin D or 25-OHD or calcidiol or calcifediol 
or dihydrotacysterol or alfacalcidol or calcitriol or colecalciferol) 
398 hits (385 after export) 
Central Search Strategy: Clinical Effectiveness of Vitamin D Testing 
Central 
("vitamin D" OR cholecalciferol OR ergocalciferol OR calciferol OR "vitamin D2" OR "vitamin D3" OR 
"hydroxyvitamin D" OR vitamin-d OR vitamin-d2 OR vitamin-d3 OR "25 hydroxyvitamin D" OR "25 
hydroxyvitamin D2" OR "25 hydroxyvitamin D3" OR "25-hydroxyvitamin D" OR "25-hydroxy-vitamin 
D" OR "25-hydroxy-vitamin D2" OR "25-hydroxy-vitamin D3" OR 25OHD OR "25-OH-vitamin D" OR 
"25-OHD" OR calcidiol OR calcifediol OR dihydrotacysterol OR alfacalcidol OR calcitriol OR colecal-
ciferol):ti,ab OR [mh "vitamin D"] 
[mh "mass screening"] OR screening:ti,ab,kw OR testing:ti,ab,kw OR "haemotologic test*":ti,ab,kw 
OR "hemotologic test*":ti,ab,kw OR "haemotological test*":ti,ab,kw OR "hemotological test*":ti,ab,kw 
OR "haemotology test*":ti,ab,kw OR "hemotology test*":ti,ab,kw 
#1 AND #2 
Hits: 451 
Epistemonikos Search Strategy: Clinical Effectiveness of Vitamin D Testing  
Epi 
(title:((title:(vitamin D) OR abstract:(vitamin D)) OR (title:(cholecalciferol) OR abstract:(cholecalcif-
erol)) OR (title:(ergocalciferol) OR abstract:(ergocalciferol)) OR (title:(calciferol) OR abstract:(calcif-
erol)) OR (title:(vitamin D2) OR abstract:(vitamin D2)) OR (title:(vitamin D3) OR abstract:(vitamin D3)) 
OR (title:(hydroxyvitamin D) OR abstract:(hydroxyvitamin D)) OR (title:(vitamin-d) OR abstract:(vita-
min-d)) OR (title:(vitamin-d2) OR abstract:(vitamin-d2)) OR (title:(vitamin-d3) OR abstract:(vitamin-
d3)) OR (title:(25 hydroxyvitamin D) OR abstract:(25 hydroxyvitamin D)) OR (title:(25 hydroxyvitamin 
D2) OR abstract:(25 hydroxyvitamin D2)) OR (title:(25 hydroxyvitamin D3) OR abstract:(25 hy-
droxyvitamin D3)) OR (title:(25-hydroxyvitamin D) OR abstract:(25-hydroxyvitamin D)) OR (title:(25-
hydroxy-vitamin D) OR abstract:(25-hydroxy-vitamin D)) OR (title:(25-hydroxy-vitamin D2) OR ab-
stract:(25-hydroxy-vitamin D2)) OR (title:(25-hydroxy-vitamin D3) OR abstract:(25-hydroxy-vitamin 
D3)) OR (title:(25OHD) OR abstract:(25OHD)) OR (title:(25-OH-vitamin D) OR abstract:(25-OH-vita-
min D)) OR (title:(25-OHD) OR abstract:(25-OHD)) OR (title:(calcidiol) OR abstract:(calcidiol)) OR 
(title:(calcifediol) OR abstract:(calcifediol)) OR (title:(dihydrotacysterol) OR abstract:(dihydrotacys-
terol)) OR (title:(alfacalcidol) OR abstract:(alfacalcidol)) OR (title:(calcitriol) OR abstract:(calcitriol)) 
OR (title:(colecalciferol) OR abstract:(colecalciferol))) OR abstract:((title:(vitamin D) OR abstract:(vit-
amin D)) OR (title:(cholecalciferol) OR abstract:(cholecalciferol)) OR (title:(ergocalciferol) OR ab-
stract:(ergocalciferol)) OR (title:(calciferol) OR abstract:(calciferol)) OR (title:(vitamin D2) OR ab-
stract:(vitamin D2)) OR (title:(vitamin D3) OR abstract:(vitamin D3)) OR (title:(hydroxyvitamin D) OR 
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abstract:(hydroxyvitamin D)) OR (title:(vitamin-d) OR abstract:(vitamin-d)) OR (title:(vitamin-d2) OR 
abstract:(vitamin-d2)) OR (title:(vitamin-d3) OR abstract:(vitamin-d3)) OR (title:(25 hydroxyvitamin D) 
OR abstract:(25 hydroxyvitamin D)) OR (title:(25 hydroxyvitamin D2) OR abstract:(25 hydroxyvitamin 
D2)) OR (title:(25 hydroxyvitamin D3) OR abstract:(25 hydroxyvitamin D3)) OR (title:(25-hydroxyvit-
amin D) OR abstract:(25-hydroxyvitamin D)) OR (title:(25-hydroxy-vitamin D) OR abstract:(25-hy-
droxy-vitamin D)) OR (title:(25-hydroxy-vitamin D2) OR abstract:(25-hydroxy-vitamin D2)) OR (ti-
tle:(25-hydroxy-vitamin D3) OR abstract:(25-hydroxy-vitamin D3)) OR (title:(25OHD) OR ab-
stract:(25OHD)) OR (title:(25-OH-vitamin D) OR abstract:(25-OH-vitamin D)) OR (title:(25-OHD) OR 
abstract:(25-OHD)) OR (title:(calcidiol) OR abstract:(calcidiol)) OR (title:(calcifediol) OR abstract:(cal-
cifediol)) OR (title:(dihydrotacysterol) OR abstract:(dihydrotacysterol)) OR (title:(alfacalcidol) OR ab-
stract:(alfacalcidol)) OR (title:(calcitriol) OR abstract:(calcitriol)) OR (title:(colecalciferol) OR ab-
stract:(colecalciferol)))) 
1515 hits 
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Appendix 2. Keyword Search Strings - Economics of Vitamin D Testing 
EMBASE Search: Economic Studies of Vitamin D Testing 
Database(s): Embase 1974 to 2019 January 04 
Search Strategy: 
 
# Searches Results 
1 (cost or costs).tw. 641415 
2 exp screening/ or screening.mp. or testing.mp. or haemotologic test*.mp. or 
hemotologic test*.mp. or haemotological test*.mp. or hemotological test*.mp. or 
haemotology test*.mp. or hemotology test*.mp. [mp=title, abstract, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword, floating subheading word, candidate term word] 
1622119 
3 ("vitamin D" or cholecalciferol or ergocalciferol or calciferol or "vitamin D2" or "vita-
min D3" or "hydroxyvitamin D" or vitamin-d or vitamin-d2 or vitamin-d3 or "25 hy-
droxyvitamin D" or "25 hydroxyvitamin D2" or "25 hydroxyvitamin D3" or "25-hy-
droxyvitamin D" or "25-hydroxy-vitamin D" or "25-hydroxy-vitamin D2" or "25-hy-
droxy-vitamin D3" or 25OHD or "25-OH-vitamin D" or 25-OHD or calcidiol or calci-
fediol or dihydrotacysterol or alfacalcidol or calcitriol or colecalciferol).tw. or exp 
vitamin D/ 
143542 
4 1 and 2 and 3 390 
 
MEDLINE search: Economic Studies of Vitamin D Testing 
Database(s): Ovid MEDLINE(R) ALL 1946 to January 04, 2019 
Search Strategy: 
 
# Searches Results 
1 (cost: or cost benefit analysis: or health care costs).mp. 629336 
2 exp mass screening/ or screening.mp. or testing.mp. or haemotologic test*.mp. or 
hemotologic test*.mp. or haemotological test*.mp. or hemotological test*.mp. or 
haemotology test*.mp. or hemotology test*.mp. 
1081735 
3 ("vitamin D" or cholecalciferol or ergocalciferol or calciferol or "vitamin D2" or "vita-
min D3" or "hydroxyvitamin D" or vitamin-d or vitamin-d2 or vitamin-d3 or "25 hy-
droxyvitamin D" or "25 hydroxyvitamin D2" or "25 hydroxyvitamin D3" or "25-hy-
droxyvitamin D" or "25-hydroxy-vitamin D" or "25-hydroxy-vitamin D2" or "25-hy-
droxy-vitamin D3" or 25OHD or "25-OH-vitamin D" or 25-OHD or calcidiol or calci-
fediol or dihydrotacysterol or alfacalcidol or calcitriol or colecalciferol).tw. or exp 
80342 
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vitamin D/ 
4 1 and 2 and 3 173 
 
CRD Search Strategy: Economic Studies of Vitamin D Testing 
CRD 
Results for: (vitamin D or cholecalciferol or ergocalciferol or calciferol or vitamin D2 or vitamin D3 or 
hydroxyvitamin D or vitamin-d or vitamin-d2 or vitamin-d3 or 25 hydroxyvitamin D or 25 hydroxyvit-
amin D2 or 25 hydroxyvitamin D3 or 25-hydroxyvitamin D or 25-hydroxy-vitamin D or 25-hydroxy-
vitamin D2 or 25-hydroxy-vitamin D3 or 25OHD or 25-OH-vitamin D or 25-OHD or calcidiol or calci-
fediol or dihydrotacysterol or alfacalcidol or calcitriol or colecalciferol) 
398 hits (385 after export) 
 
Appendix 3. Keyword Search Strings - Clinical Effectiveness of Vitamin D Supplementation 
Database(s): Ovid MEDLINE(R) ALL 1946 to January 15, 2019  
Search Strategy: 
 
# Searches Results 
1 ("vitamin D" or cholecalciferol or ergocalciferol or calciferol or "vitamin D2" or "vitamin 
D3" or "hydroxyvitamin D" or vitamin-d or vitamin-d2 or vitamin-d3 or "25 hydroxyvita-
min D" or "25 hydroxyvitamin D2" or "25 hydroxyvitamin D3" or "25-hydroxyvitamin 
D" or "25-hydroxy-vitamin D" or "25-hydroxy-vitamin D2" or "25-hydroxy-vitamin D3" 
or 25OHD or "25-OH-vitamin D" or 25-OHD or calcidiol or calcifediol or dihydrotacys-
terol or alfacalcidol or calcitriol or colecalciferol).tw. or exp vitamin D/ 
80987 
2 (Meta-Analysis as Topic/ or meta analy$.tw. or metaanaly$.tw. or Meta-Analysis/ or 
(systematic adj (review$1 or overview$1)).tw. or exp Review Literature as Topic/ or 
cochrane.ab. or embase.ab. or (psychlit or psyclit).ab. or (psychinfo or psycinfo).ab. 
or (cinahl or cinhal).ab. or science citation index.ab. or bids.ab. or cancerlit.ab. or ref-
erence list$.ab. or bibliograph$.ab. or hand-search$.ab. or relevant journals.ab. or 
manual search$.ab. or ((selection criteria or data extraction).ab. and review/)) not 
(comment/ or letter/ or editorial/) 
289419 
3 1 and 2 2074 
4 limit 3 to (humans and yr="2000 -Current") 1671 
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Database(s): Embase 1974 to 2019 January 15  
Search Strategy: 
 
# Searches Results 
1 ("vitamin D" or cholecalciferol or ergocalciferol or calciferol or "vitamin D2" or "vita-
min D3" or "hydroxyvitamin D" or vitamin-d or vitamin-d2 or vitamin-d3 or "25 hy-
droxyvitamin D" or "25 hydroxyvitamin D2" or "25 hydroxyvitamin D3" or "25-hy-
droxyvitamin D" or "25-hydroxy-vitamin D" or "25-hydroxy-vitamin D2" or "25-hy-
droxy-vitamin D3" or 25OHD or "25-OH-vitamin D" or 25-OHD or calcidiol or calci-
fediol or dihydrotacysterol or alfacalcidol or calcitriol or colecalciferol).tw. or exp vit-
amin D/ 
144407 
2 exp Meta Analysis/ 156319 
3 ((meta adj analy$) or metaanalys$).tw. 184897 
4 (systematic adj (review$1 or overview$1)).tw. 165962 
5 or/2-4 316973 
6 cancerlit.ab. 725 
7 cochrane.ab. 87178 
8 embase.ab. 91275 
9 (psychlit or psyclit).ab. 992 
10 (psychinfo or psycinfo).ab. 24262 
11 (cinahl or cinhal).ab. 26703 
12 science citation index.ab. 3343 
13 bids.ab. 612 
14 or/6-13 142820 
15 reference lists.ab. 17507 
16 bibliograph$.ab. 20716 
17 hand-search$.ab. 7444 
18 manual search$.ab. 4695 
19 relevant journals.ab. 1312 
20 or/15-19 46527 
21 data extraction.ab. 21482 
22 selection criteria.ab. 34151 
23 21 or 22 53501 
24 review.pt. 2396615 
25 23 and 24 26637 
26 letter.pt. 1054048 
27 editorial.pt. 593677 
28 animal/ 1397915 
29 human/ 1911171
8 
30 28 not (28 and 29) 1024410 
31 or/26-27,30 2655670 
32 5 or 14 or 20 or 25 376853 
33 32 not 31 366672 
34 1 and 33 3653 
35 limit 34 to (human and yr="2000 -Current") 3445 
36 limit 35 to conference abstract status 502 
37 35 not 36 2943 
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CRD 
 
Results for: (vitamin D or cholecalciferol or er-
gocalciferol or calciferol or vitamin D2 or vitamin 
D3 or hydroxyvitamin D or vitamin-d or vitamin-
d2 or vitamin-d3 or 25 hydroxyvitamin D or 25 
hydroxyvitamin D2 or 25 hydroxyvitamin D3 or 
25-hydroxyvitamin D or 25-hydroxy-vitamin D or 
25-hydroxy-vitamin D2 or 25-hydroxy-vitamin D3 
or 25OHD or 25-OH-vitamin D or 25-OHD or cal-
cidiol or calcifediol or dihydrotacysterol or al-
facalcidol or calcitriol or colecalciferol) 
398 hits 
 
 
Epistemonikos 
 
(title:((title:(vitamin D) OR abstract:(vitamin D)) OR (title:(cholecalciferol) OR abstract:(cholecalcif-
erol)) OR (title:(ergocalciferol) OR abstract:(ergocalciferol)) OR (title:(calciferol) OR abstract:(calcif-
erol)) OR (title:(vitamin D2) OR abstract:(vitamin D2)) OR (title:(vitamin D3) OR abstract:(vitamin D3)) 
OR (title:(hydroxyvitamin D) OR abstract:(hydroxyvitamin D)) OR (title:(vitamin-d) OR abstract:(vita-
min-d)) OR (title:(vitamin-d2) OR abstract:(vitamin-d2)) OR (title:(vitamin-d3) OR abstract:(vitamin-
d3)) OR (title:(25 hydroxyvitamin D) OR abstract:(25 hydroxyvitamin D)) OR (title:(25 hydroxyvitamin 
D2) OR abstract:(25 hydroxyvitamin D2)) OR (title:(25 hydroxyvitamin D3) OR abstract:(25 hy-
droxyvitamin D3)) OR (title:(25-hydroxyvitamin D) OR abstract:(25-hydroxyvitamin D)) OR (title:(25-
hydroxy-vitamin D) OR abstract:(25-hydroxy-vitamin D)) OR (title:(25-hydroxy-vitamin D2) OR ab-
stract:(25-hydroxy-vitamin D2)) OR (title:(25-hydroxy-vitamin D3) OR abstract:(25-hydroxy-vitamin 
D3)) OR (title:(25OHD) OR abstract:(25OHD)) OR (title:(25-OH-vitamin D) OR abstract:(25-OH-vita-
min D)) OR (title:(25-OHD) OR abstract:(25-OHD)) OR (title:(calcidiol) OR abstract:(calcidiol)) OR 
(title:(calcifediol) OR abstract:(calcifediol)) OR (title:(dihydrotacysterol) OR abstract:(dihydrotacys-
terol)) OR (title:(alfacalcidol) OR abstract:(alfacalcidol)) OR (title:(calcitriol) OR abstract:(calcitriol)) 
OR (title:(colecalciferol) OR abstract:(colecalciferol))) OR abstract:((title:(vitamin D) OR abstract:(vit-
amin D)) OR (title:(cholecalciferol) OR abstract:(cholecalciferol)) OR (title:(ergocalciferol) OR ab-
stract:(ergocalciferol)) OR (title:(calciferol) OR abstract:(calciferol)) OR (title:(vitamin D2) OR ab-
stract:(vitamin D2)) OR (title:(vitamin D3) OR abstract:(vitamin D3)) OR (title:(hydroxyvitamin D) OR 
abstract:(hydroxyvitamin D)) OR (title:(vitamin-d) OR abstract:(vitamin-d)) OR (title:(vitamin-d2) OR 
abstract:(vitamin-d2)) OR (title:(vitamin-d3) OR abstract:(vitamin-d3)) OR (title:(25 hydroxyvitamin D) 
OR abstract:(25 hydroxyvitamin D)) OR (title:(25 hydroxyvitamin D2) OR abstract:(25 hydroxyvitamin 
D2)) OR (title:(25 hydroxyvitamin D3) OR abstract:(25 hydroxyvitamin D3)) OR (title:(25-hydroxyvita-
min D) OR abstract:(25-hydroxyvitamin D)) OR (title:(25-hydroxy-vitamin D) OR abstract:(25-hydroxy-
vitamin D)) OR (title:(25-hydroxy-vitamin D2) OR abstract:(25-hydroxy-vitamin D2)) OR (title:(25-hy-
droxy-vitamin D3) OR abstract:(25-hydroxy-vitamin D3)) OR (title:(25OHD) OR abstract:(25OHD)) 
OR (title:(25-OH-vitamin D) OR abstract:(25-OH-vitamin D)) OR (title:(25-OHD) OR abstract:(25-
OHD)) OR (title:(calcidiol) OR abstract:(calcidiol)) OR (title:(calcifediol) OR abstract:(calcifediol)) OR 
(title:(dihydrotacysterol) OR abstract:(dihydrotacysterol)) OR (title:(alfacalcidol) OR abstract:(alfacal-
cidol)) OR (title:(calcitriol) OR abstract:(calcitriol)) OR (title:(colecalciferol) OR abstract:(colecalcif-
erol)))) 
SRs 1,484 
BSs 29 
All 4,277 
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Appendix 4. Characteristics of Clinical Studies of Vitamin D Testing  
Main author Year(s) Title Countries (if reported) Group at high 
risk of severe 
vitamin D defi-
ciency defined 
by FCN 
FCN at 
risk group 
(sub-
group) 
Type of 
study 
Number of studies in review Number of studies rel-
evant for our analysis 
CADTH  73 2014  Vitamin D Testing for Northern Popu-
lations: Clinical and Cost-Effective-
ness and Guidelines 
n/a n/a (any)  SR 1 HTA, 0 SRs, 0 meta-anal-
yses, 0 RCTs, 0 non-random-
ized studies, 0 economic eval-
uations, 0 evidence-based 
guidelines 
0  
CADTH  74 2015 Vitamin D testing in the general pop-
ulation: clinical and cost-effective-
ness and guidelines 
n/a n/a (any)  SR Two SRs, 1 non-randomized 
study, one economic evalua-
tion, and two evidence-based 
guidelines 
0 (study design in the 
one non-randomized 
study was not eligible for 
our report) 
LeBlanc  72 2015 Screening for vitamin D deficiency: a 
systematic review for the U.S. Pre-
ventive Services Task Force. 
n/a n/a (any adults)  SR 0 randomised trials on vitamin 
D screening versus no screen-
ing on clinical outcomes 
0 
*CADTH= Canadian Agency for Drugs and Technologies in Health. FCN= Federal Commission for Nutrition. HTA= health technology assessment. n/a=not applicable. 
RCT= randomised controlled trial. SR= systematic review  
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Appendix 5. Characteristics of Economic Analyses of Vitamin D Testing 
Authors  Year  Title Country  FCN risk 
group  
Type of 
study  
Intervention  Comparator  Modelling 
approach  
Time 
horizon  
Population  
YHEC for 
NICE  24 
2014 An Economic Evalua-
tion of Interventions to 
Improve the Uptake of 
Vitamin D Supplements 
in England and Wales 
United 
Kingdom 
Analysis 
1: Older 
adults. 
Analysis 
2: Peo-
ple with 
darker 
skin 
Costing 
analysis 
Testing the whole popula-
tion for vitamin D deficiency 
and providing vitamin D 
supplementation only to 
those who are deficient 
Vitamin D supple-
mentation without 
prior testing 
N/A Not 
specified 
Analysis 1: 
Older people 
aged 65 and 
over; Analysis 
2: People with 
darker skin. 
Lee ,We-
ber, Co-
lon-Emeric  
75 
2012 Cost-effectiveness 
analysis of screening 
for vitamin D insuffi-
ciency to prevent falls 
and fractures among 
community-dwelling 
older adults 
USA Older 
adults 
Cost 
effective-
ness 
analysis 
Population screening for 
vitamin D insufficiency 
No vitamin D 
screening or sup-
plementation 
Markov 
decision 
model, 
Treeage 
software 
3 years Analysis 1: 
community 
dwelling fe-
males aged 
65-80 years. 
Analysis 2: 
community 
dwelling 
males aged 
65-80 years.  
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Authors  Year  Title Country  FCN risk 
group  
Type of 
study  
Intervention  Comparator  Modelling 
approach  
Time 
horizon  
Population  
Zarca, Du-
rand-Za-
leski, et al. 
76 
2014 Cost-effectiveness 
analysis of hip fracture 
prevention with vitamin 
D supplementation: a 
Markov micro-simula-
tion model applied to 
the French population 
over 65 years old with-
out previous hip frac-
ture. 
France Older 
adults 
Cost  
effective-
ness 
analysis 
Analysis 1: Population 
screening for vitamin D in-
sufficiency followed by 
treatment based on the vit-
amin D serum level. Analy-
sis 2: Supplementation with 
a serum level check 3 
months after initiation and 
subsequent treatment ad-
aptation. 
Analysis 1: no 
treatment. Analy-
sis 2: Population 
screening for vita-
min D insuffi-
ciency followed 
by treatment 
based on the vita-
min D serum 
level.  
Markov 
micro-sim-
ulation 
model, R 
statistical 
software 
Lifetime Adults with 
starting age 
of 65 years 
without previ-
ous hip frac-
ture 
KEY: *FCN= Swiss Federal Commission for Nutrition. YHEC= York Health Economics Consortium. NICE= National Institute for Care and Health Excellence. n/a= not applicable 
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Appendix 6. Results of Economic Analyses of Vitamin D Testing 
 
Author  Year  Mean in-
tervention 
costs per 
person 
Mean 
compara-
tor costs 
per per-
son 
Mean in-
tervention 
effect per 
person 
Mean 
compara-
tor effect 
per per-
son 
ICER Cur-
rency 
Annual 
dis-
count 
rate 
(costs) 
Annual 
discount 
rate (out-
comes) 
Thresh-
old 
Sensitivity analysis 
YHEC 
for 
NICE 
24 
2014 Analysis 1: 
52.09. 
Analysis 2: 
30.87 
Analysis 1: 
49.33. 
Analysis 2: 
20.69. 
n/a n/a N/A GBP, 
year 
2012 
0% 0% n/a One-way sensitivity analyses were un-
dertaken for the population of older 
people aged 65 and over, finding re-
sults were sensitive to prevalence of 
vitamin D deficiency, the cost of the 
test and the cost of the supplement 
Lee 
,We-
ber, 
Colon-
Emeric 
75 
2012 Not re-
ported* 
Not re-
ported* 
Not re-
ported* 
Not re-
ported* 
Analysis 
1: 
$16,117 
per 
QALY 
gained. 
Analysis 
2: 
$13,182 
per 
QALY 
gained 
USD, 
year 
2011 
3% 3% $50,000 
per 
QALY 
Analysis 1: PSA indicated population 
screening most cost-effective strategy 
in 52.8% of simulations, vitamin D sup-
plementation without prior vitamin D 
testing cost-effective in 36.3% of simu-
lations. Analysis 2: PSA indicated pop-
ulation screening most cost-effective 
strategy in 54.3% of simulations, vita-
min D supplementation without prior 
vitamin D testing cost-effective in 
38.2% of simulations 
 HTA Scoping Report 60 
Author  Year  Mean in-
tervention 
costs per 
person 
Mean 
compara-
tor costs 
per per-
son 
Mean in-
tervention 
effect per 
person 
Mean 
compara-
tor effect 
per per-
son 
ICER Cur-
rency 
Annual 
dis-
count 
rate 
(costs) 
Annual 
discount 
rate (out-
comes) 
Thresh-
old 
Sensitivity analysis 
Zarca, 
Du-
rand-
Za-
leski, 
et al  76 
2014 Analysis 1: 
€709.21. 
Analysis 2: 
€684.63 
Analysis 1: 
€684.63. 
Analysis 2: 
€606.89 
Analysis 1: 
11.148 
QALYs. 
Analysis 2: 
11.143 
QALYs 
Analysis 1: 
11.143 
QALYs. 
Analysis 2: 
11.128 
QALYs.  
Analysis 
1: €9,104 
per 
QALY 
gained. 
Analysis 
2: €5,219 
per 
QALY 
gained.  
Euros, 
year 
2012  
3% 3% €20,000 
per 
QALY 
Analysis 1: For willingness-to-pay of 
over €6,000 per QALY, “Population 
screening for vitamin D insufficiency 
followed by treatment” strategy had 
the greatest probability of being cost-
effective 
*The authors of this study neglected to report absolute costs and QALYs for each treatment strategy.   
KEY: **ICER=incremental cost-effectiveness ratio. n/a= not applicable. QALY= quality adjusted life year. GBP= Great British pounds. USD= USA dollars.
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Appendix 7. Characteristics of the Umbrella and Systematic Reviews of Vitamin D Supplementation (n=21) 
 
Main author Year(s) Title Countries (if reported)* FCN at risk group (sub-
group) 
Type of 
study 
Number of 
studies in re-
view 
Number of studies rele-
vant for our analysis 
C
od
e 
fo
r 
an
al
ys
is
 (t
o 
m
at
ch
 w
ith
 
re
su
lts
 in
 
ap
pe
nd
ix
 8
) 
PEOPLE WITH BONE DISORDERS 
Maclean 81 2008 Systematic Review: Comparative Effectiveness of 
Treatments to Prevent Fractures in Men and Women 
with Low Bone Density or Osteoporosis 
Predominantly United 
Kingdom 
High risk of fracture Umbrella 
review 
24 MAs 2 SRs (first SR compris-
ing a total of 2745 partici-
pants; second SR com-
prising a total of 109 par-
ticipants) 
1a 
Maclean  81 2008 Systematic Review: Comparative Effectiveness of 
Treatments to Prevent Fractures in Men and Women 
with Low Bone Density or Osteoporosis 
Not stated High risk of fracture Umbrella 
review 
24 MAs 1 SR, 1 trial comprising a 
total of 213 participants 
1b 
Maclean  81 2008 Systematic Review: Comparative Effectiveness of 
Treatments to Prevent Fractures in Men and Women 
with Low Bone Density or Osteoporosis 
United Kingdom High risk of fracture Umbrella 
review 
24 MAs 1 SR, 3 trials comprising 
a total of 2820 partici-
pants 
1c 
Egan 86 2008 Factors associated with a second hip fracture: a sys-
tematic review 
United Kingdom Individuals who have 
previously fractured a 
hip 
System-
atic re-
view 
4 RCTs 1 RCT; 76 participants in 
relevant groups 
2 
Parikh  87 2009 Pharmacological Management of Osteoporosis in 
Nursing Home Populations: A Systematic Review 
France, Switzerland Female nursing home 
residents; at least 79 
years of age (thus likely 
to have osteoporosis). 
System-
atic re-
view 
8 RCTs 3 RCTs 3 
Qaseem  85 2017 Treatment of Low Bone Density or Osteoporosis to 
Prevent Fractures in Men and Women: A Clinical 
Practice Guideline Update From the American College 
of Physicians 
Not stated Low bone density or os-
teoporosis 
System-
atic re-
view 
Not stated 68 studies 4 
OLDER ADULTS 
Bolland sub-
group 77 
2018 Effects of vitamin D supplementation on musculoskel-
etal health: a systematic review, meta-analysis, and 
trial sequential analysis 
Large proportion of tri-
als from Europe, Aus-
tralia, USA (may also 
be some from LMICs) 
Mostly (not exclusively) 
adults aged 65 and over 
Um-
brella/sys
tematic 
review 
42 RCTs on 
total fracture 
19 RCTs included in sub-
group meta-analysis of 
daily vitamin D supple-
mentation  
5a 
Bolland sub-
group 77 
2018 Effects of vitamin D supplementation on musculoskel-
etal health: a systematic review, meta-analysis, and 
trial sequential analysis 
Large proportion from 
Europe, Australia, USA 
(may also be some 
from LMICs) 
Mostly (not exclusively) 
adults aged 65 and over 
Um-
brella/sys
tematic 
review 
37 RCTs on 
falls 
18 RCTs included in sub-
group meta-analysis of 
daily vitamin D supple-
mentation 
5b 
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Main author Year(s) Title Countries (if reported)* FCN at risk group (sub-
group) 
Type of 
study 
Number of 
studies in re-
view 
Number of studies rele-
vant for our analysis 
C
od
e 
fo
r 
an
al
ys
is
 (t
o 
m
at
ch
 w
ith
 
re
su
lts
 in
 
ap
pe
nd
ix
 8
) 
Bolland sub-
group  77 
2018 Effects of vitamin D supplementation on musculoskel-
etal health: a systematic review, meta-analysis, and 
trial sequential analysis 
Large proportion from 
Europe, Australia, USA 
(may also be some 
from LMICs) 
Mostly (not exclusively) 
adults aged 65 and over 
Um-
brella/sys
tematic 
review 
41 RCTs on 
BMD 
18 RCTs included in sub-
group meta-analysis of 
daily vitamin D supple-
mentation 
5c 
Bjelakovic 98 2014 Vitamin D supplementation for prevention of mortality 
in adults 
USA, UK, Finland Postmenopausal women 
and older men 
Cochran
e review 
159 trials 4 randomised trials; 
44,492 participants 
6 
Husebo 99 2016 Identifying and Managing Pain in People with Alz-
heimer’s Disease and Other Types of Dementia: A 
Systematic Review 
Finland Advanced dementia pa-
tients 
System-
atic re-
view 
12 studies 1 RCT; 202 participants 7 
Poscia  90 2017 Effectiveness of nutritional interventions addressed to 
elderly persons: umbrella systematic review with 
meta-analysis 
Mostly USA, Canada, 
UK, Sweden, Nether-
lands 
≥65 years old Umbrella 
review 
28 SRs 4 SRs (17 RCTs) 8a 
Poscia  90 2017 Effectiveness of nutritional interventions addressed to 
elderly persons: umbrella systematic review with 
meta-analysis 
Mostly USA, Canada, 
UK, Sweden, Nether-
lands 
≥65 years old Umbrella 
review 
28 SRs 3 SRs (9 RCTs) 8b 
Poscia  90 2017 Effectiveness of nutritional interventions addressed to 
elderly persons: umbrella systematic review with 
meta-analysis 
Mostly USA, Canada, 
UK, Sweden, Nether-
lands 
≥65 years old Umbrella 
review 
28 SRs 1 SR (15 RCTs, 28,271 
participants) 
8c 
Poscia  90 2017 Effectiveness of nutritional interventions addressed to 
elderly persons: umbrella systematic review with 
meta-analysis 
Mostly USA, Canada, 
UK, Sweden, Nether-
lands 
≥65 years old Umbrella 
review 
28 SRs 1 SR (10 RCTs, 49,853 
participants) 
8d 
Poscia  90 2017 Effectiveness of nutritional interventions addressed to 
elderly persons: umbrella systematic review with 
meta-analysis 
Mostly USA, Canada, 
UK, Sweden, Nether-
lands 
≥65 years old Umbrella 
review 
28 SRs 1 SR (6 RCTs, 46,794 
participants) 
8e 
Poscia   90 2017 Effectiveness of nutritional interventions addressed to 
elderly persons: umbrella systematic review with 
meta-analysis 
Mostly USA, Canada, 
UK, Sweden, Nether-
lands 
≥65 years old Umbrella 
review 
28 SRs 1 SR (18 RCTs, 22,854 
participants) 
8f 
Scragg  91 2012 Do we need to take calcium with vitamin D to prevent 
falls, fractures and death? 
Europe and USA ≥60 years old Umbrella 
review 
24 SRs 3 SRs (21 RCTs, 12,821 
participants) 
9a 
Scragg  91 2012 Do we need to take calcium with vitamin D to prevent 
falls, fractures and death? 
Europe and USA ≥60 years old  Umbrella 
review 
24 SRs 4 SRs (34 RCTs) 9b 
Scragg  91 2012 Do we need to take calcium with vitamin D to prevent 
falls, fractures and death? 
Europe and USA ≥60 years old Umbrella 
review 
24 SRs 2 SRs (22 RCTs, 
223,048 participants) 
9c 
Stubbs  93 2015 What works to prevent falls in older adults dwelling in 
long term care facilities and hospitals? An umbrella re-
view of meta-analyses of randomised controlled trials. 
Not stated ≥60 years old in care fa-
cilities 
Umbrella 
review 
26 SRs 5 SRs (30 RCTs) 10a 
Stubbs  88 2015 What Works to Prevent Falls in Community-Dwelling 
Older Adults? Umbrella Review of Meta-analyses of 
Randomized Controlled Trials 
Not stated  ≥60 years old Umbrella 
review 
16 SRs 4 SRs (32 RCTs) 11a 
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Main author Year(s) Title Countries (if reported)* FCN at risk group (sub-
group) 
Type of 
study 
Number of 
studies in re-
view 
Number of studies rele-
vant for our analysis 
C
od
e 
fo
r 
an
al
ys
is
 (t
o 
m
at
ch
 w
ith
 
re
su
lts
 in
 
ap
pe
nd
ix
 8
) 
Stubbs  88 2015 What Works to Prevent Falls in Community-Dwelling 
Older Adults? Umbrella Review of Meta-analyses of 
Randomized Controlled Trials 
Not stated  ≥65 years old Umbrella 
review 
16 SRs 5 SRs (36 RCTs) 11b 
Medical Ad-
visory  89 
2008 Prevention of Falls and Fall Related Injuries in Com-
munity-Dwelling Seniors 
Switzerland, New Zea-
land, UK 
≥65 years old, commu-
nity dwelling  
Umbrella 
review 
17 SRs 3 RCT (752 participants) 12a 
Medical Ad-
visory  89 
2008 Prevention of Falls and Fall Related Injuries in Com-
munity-Dwelling Seniors 
Germany ≥65 years old, commu-
nity dwelling  
Umbrella 
review 
17 SRs 1 RCTs (148 women) 12b 
Medical Ad-
visory  89 
2008 Prevention of Falls and Fall Related Injuries in Com-
munity-Dwelling Seniors 
Switzerland ≥65 years old, commu-
nity dwelling  
Umbrella 
review 
17 SRs 1 RCTs (2566 partici-
pants) 
12c 
Medical Ad-
visory  89 
2008 Prevention of Falls and Fall Related Injuries in Com-
munity-Dwelling Seniors 
UK ≥65 years old, commu-
nity dwelling  
Umbrella 
review 
17 SRs 2 RCTs (3,980 partici-
pants) 
12d 
De Spiege-
leer95  
2018 Pharmacological Interventions to Improve Muscle 
Mass, Muscle Strength and Physical Performance in 
Older People: An Umbrella Review of Systematic Re-
views and Meta-analyses 
Europe, USA, Australia, 
Brazil, Canada and Ja-
pan 
≥65 years old Umbrella 
review 
7 SRs 2 SRs (3,049 partici-
pants) 
13a 
De Spiege-
leer95  
2018 Pharmacological Interventions to Improve Muscle 
Mass, Muscle Strength and Physical Performance in 
Older People: An Umbrella Review of Systematic Re-
views and Meta-analyses 
Europe, USA, Australia, 
Brazil, Canada and Ja-
pan 
≥65 years old Umbrella 
review 
7 SRs 2 SRs (1,223 partici-
pants) 
13b 
Vestergaard 
94 
2010 Fracture prevention in postmenopausal women Not stated > 60 years old women Umbrella 
review 
71 SRs 1 SR (5 RCTs, 9,138 
participants) 
14a 
Vestergaard  
94 
2010 Fracture prevention in postmenopausal women Not stated > 60 years old women Umbrella 
review 
71 SRs 2 SRs (13 RCTs, 44,065 
participants) 
14b 
Vestergaard  
94 
2010 Fracture prevention in postmenopausal women Not stated > 60 years old women Umbrella 
review 
71 SRs 2 SRs (7 RCTs, 96,121 
participants) 
14c 
Vestergaard 
94 
2010 Fracture prevention in postmenopausal women Not stated > 60 years old women Umbrella 
review 
71 SRs 3 SRs (18 RCTs, 
110,010 participants) 
14d 
Theodoratou 
92 
2014 Vitamin D and multiple health outcomes: umbrella re-
view of systematic reviews and meta-analyses of ob-
servational studies and randomised trials 
Not stated > 60 years old Umbrella 
review 
87 MAs  10 RCTs (34,144 partici-
pants) 
15a 
Theodoratou 
92 
2014 Vitamin D and multiple health outcomes: umbrella re-
view of systematic reviews and meta-analyses of ob-
servational studies and randomised trials 
Not stated > 60 years old Umbrella 
review 
87 MAs  10 RCTs (25,016 partici-
pants) 
15b 
Theodoratou 
92 
2014 Vitamin D and multiple health outcomes: umbrella re-
view of systematic reviews and meta-analyses of ob-
servational studies and randomised trials 
UK, Switzerland,New 
Zealand,Japan, Ger-
many, USA, Australia  
> 60 years old Umbrella 
review 
87 MAs  3 RCTs (314 partici-
pants) 
15c 
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Bassatne 103 2019 Vitamin D supplementation in obesity and during 
weight loss: A review of randomized controlled trials. 
Norway Mean BMI of participants 
≥30 kg/m2 in at least 
one arm) without weight 
loss 
System-
atic re-
view 
26 1 RCT 16 
PREGNANT WOMEN 
Browne (and 
De-Regil)  
104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
Iran, India Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 4 trials, 499 
women, 
17a 
Browne (and 
De-Regil)  
104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
United Kingdom Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 1 trial, 126 women, 17b 
Browne (and 
De-Regil)  
104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
Iran, France, New Zea-
land, United Kingdom, 
Bangladesh, India 
Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 7 trials, 1640 
women, 
17c 
Browne (and 
De-Regil)  
104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
Iran, India Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 4 trials, 446 
women, 
17d 
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Browne (and 
De-Regil)  
104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
Iran, India Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 4 trials, 1174 
women, 
17e 
Browne (and 
De-Regil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
Iran Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 1 trial, 54 women, 17f 
Browne (and 
De-Regil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
Brazil, Iran Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 2 trials, 110 
women, 
17g 
Browne (and 
De-Regil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR pre-
sented) 
Vitamin D supplementation for women during preg-
nancy 
Iran, Brazil Pregnant women Umbrella 
re-
view/sys-
tematic 
review 
25 SRs 1 SR, 5 trials, 942 
women, 
17h 
Harvey  106 2014 Vitamin D supplementation in pregnancy: A systematic 
review 
United Kingdom Pregnant women System-
atic re-
view 
76 studies 1 trial 18 
Cranney  33 2007 Effectiveness and safety of vitamin D in relation to 
bone health 
 Women of reproductive 
age 
System-
atic re-
view 
167 0 trials 19a 
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group) 
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ix
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) 
Cranney¨ 33 2007 Effectiveness and safety of vitamin D in relation to 
bone health 
n/a Women of reproductive 
age 
System-
atic re-
view 
167 0 trials 19b 
ATHLETES 
Farrokhyar  
108 
2017 Effects of Vitamin D Supplementation on Serum 25-
Hydroxyvitamin D Concentrations and Physical Perfor-
mance in Athletes: A Systematic Review and Meta-
analysis of Randomized Controlled Trials 
n/a 
 
System-
atic re-
view 
13 RCTs 
(532 athletes) 
0 20a 
Farrokhyar  
108 
2017 Effects of Vitamin D Supplementation on Serum 25-
Hydroxyvitamin D Concentrations and Physical Perfor-
mance in Athletes: A Systematic Review and Meta-
analysis of Randomized Controlled Trials 
Not stated 
 
System-
atic re-
view 
13 RCTs 
(532 athletes) 
7 20b 
Chiang 109 2017 Effects of Vitamin D Supplementation on Muscle 
Strength in Athletes: A Systematic Review 
United Kingdom, USA healthy, athletic partici-
pants aged 18-45 years 
System-
atic re-
view 
6 trials (5 
RCTs, 1 non-
randomised 
controlled 
trial) 
4 21a 
Chiang  109 2017 Effects of Vitamin D Supplementation on Muscle 
Strength in Athletes: A Systematic Review 
USA healthy, athletic partici-
pants aged 18-45 years 
System-
atic re-
view 
6 trials (5 
RCTs, 1 non-
randomised 
controlled 
trial) 
2 21b 
 
Key: MA=meta-analysis. RCT=randomized controlled trial. SR=systematic review. UR=umbrella review. USA=United States of America. UK=United Kingdom. FCN= Swiss Federal Commission for Nutrition. 
n/a=not applicable.  
*Refers to the countries in which the underlying trials were conducted. **Some studies appear more than once in table as they address multiple outcomes/vitamin D modalities for a particular risk group  
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 PERSONS WITH BONE DISORDERS 
1a Maclean 81 2008 Systematic Review: Com-
parative Effectiveness of 
Treatments to Prevent 
Fractures in Men and 
Women with Low Bone 
Density or Osteoporosis 
1 High risk of 
fracture 
1966-
2007 
Not 
stated 
Vitamin D Placebo Vertebral 
fracture  
SR1: RR=3.97 
(95% CI: 0.44, 
35.45); SR2: 
RR=1.02 (95% 
CI: 0.44 to 
2.32)  
Both SRs reported that vita-
min D did not affect risk of 
vertebral fracture 
6 
1b Maclean81 2008 Systematic Review: Com-
parative Effectiveness of 
Treatments to Prevent 
Fractures in Men and 
Women with Low Bone 
Density or Osteoporosis 
1 High risk of 
fracture 
1966-
2007 
Not 
stated 
Vitamin D Placebo Non-verte-
bral frac-
ture 
5% (n=5) of vit-
amin D group 
experienced 
non-vertebral 
fracture; 11% 
(n=12) of pla-
cebo group ex-
perienced non-
vertebral frac-
ture; RR was 
not statistically 
significant (and 
not numerically 
reported) 
Based on 1 trial of 213 par-
ticipants, vitamin D did not 
significantly affect risk of 
non-vertebral fracture 
6 
1c Maclean 81 2008 Systematic Review: Com-
parative Effectiveness of 
Treatments to Prevent 
Fractures in Men and 
Women with Low Bone 
Density or Osteoporosis 
1 High risk of 
fracture 
1966-
2007 
1 year 
to 5 
years 
Vitamin D Placebo Hip frac-
ture 
RR=1.08 (95% 
CI: 0.72 to 
1.62) 
Based on 3 trials, vitamin D 
did not significantly affect risk 
of hip fracture 
6 
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2 Egan86 2008 Factors associated with a 
second hip fracture: a sys-
tematic review 
1 Individuals 
who have 
previously 
fractured a 
hip 
Incep-
tion-
2006 
12 
months 
Daily 800 
IU Vita-
min D3 
plus 1g 
calcium 
No treat-
ment 
Second 
fracture 
within 12 
months of 
the first 
8% (n=3) of vit-
amin D plus 
calcium group 
experienced 
second frac-
ture; 14% (n=5) 
of placebo 
group experi-
enced second 
fracture 
Due to small sample size, 
unable to assess whether vit-
amin D plus calcium signifi-
cantly reduces second frac-
ture risk 
5 
3 Parikh87 2009 Pharmacological Manage-
ment of Osteoporosis in 
Nursing Home Popula-
tions: A Systematic Re-
view 
1 Female 
nursing 
home resi-
dents; at 
least 79 
years of 
age (thus 
likely to 
have oste-
oporosis). 
1974-
2006 
1.5 to 
2 years 
800 IU 
vitamin D 
daily plus 
calcium 
Placebo 
or no in-
terven-
tion 
Bone min-
eral den-
sity 
All 3 trials 
found vitamin D 
plus calcium 
was associated 
with higher 
BMD out-
comes; how-
ever confi-
dence intervals 
were not re-
ported 
The evidence base sup-
ported the use of vitamin D 
at a dose of 800IU or greater 
in NH populations for improv-
ing BMD 
5 
4 Qaseem85 2017 Treatment of Low Bone 
Density or Osteoporosis to 
Prevent Fractures in Men 
and Women: A Clinical 
Practice Guideline Update 
From the American Col-
lege of Physicians 
1 Low bone 
density or 
osteoporo-
sis 
2005-
2016 
Not 
stated 
Vitamin D  Various Fracture The overall ef-
fect of vitamin 
D monotherapy  
in reducing 
fracture risk is 
uncertain due 
to mixed find-
ings across 
MAs/trials; evi-
dence is of a 
moderate qual-
ity (GRADE as-
sessment) 
n/a 3 
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5a Bolland 
subgroup 77 
2018 Effects of vitamin D sup-
plementation on musculo-
skeletal health: a system-
atic review, meta-analysis, 
and trial sequential analy-
sis 
2 
 
Data-
base 
search 
from 
2015-
2018 
as an 
up-
date 
to pre-
vi-
ously 
pub-
lished 
meta-
anal-
yses 
Esti-
mated 
at 1-60 
months 
Subgroup 
receiving 
daily vita-
min D 
supple-
mentation 
Un-
treated 
controls, 
placebo, 
or lower-
dose vita-
min D 
supple-
ments 
Total frac-
ture 
RR=0.97, (95% 
CI: 0·88 to 
1·07) 
Daily vitamin D supplementa-
tion does not appear to pre-
vent total fracture in older 
adults. 
6 
5b Bolland 
subgroup 77 
2018 Effects of vitamin D sup-
plementation on musculo-
skeletal health: a system-
atic review, meta-analysis, 
and trial sequential analy-
sis 
2 
 
Data-
base 
search 
from 
2015-
2018 
as an 
up-
date 
to pre-
vi-
ously 
pub-
lished 
meta-
anal-
yses 
Esti-
mated 
at 1-60 
months 
Subgroup 
receiving 
daily vita-
min D 
supple-
mentation 
Un-
treated 
controls, 
placebo, 
or lower-
dose vita-
min D 
supple-
ments 
Falls RR=0.92, (95% 
CI: 0·87 to 
0.98) 
Daily vitamin D supplementa-
tion resulted in a statistically 
significant reduction in falls in 
older adults. 
6 
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5c Bolland 
subgroup 77 
2018 Effects of vitamin D sup-
plementation on musculo-
skeletal health: a system-
atic review, meta-analysis, 
and trial sequential analy-
sis 
2 Mostly (not 
exclu-
sively) 
adults 
aged 65 
and over 
Data-
base 
search 
from 
2015-
2018 
as an 
up-
date 
to pre-
vi-
ously 
pub-
lished 
meta-
anal-
yses 
Esti-
mated 
at 1-60 
months 
Subgroup 
receiving 
daily vita-
min D 
supple-
mentation 
Un-
treated 
controls, 
placebo, 
or lower-
dose vita-
min D 
supple-
ments 
Lumbar 
spine BMD 
(Assumed) 
Weighted mean 
percentage dif-
fer-
ence=0.10%; 
95% CI: -0.21% 
to 0.41% 
Daily vitamin D supplementa-
tion does not appear to have 
a clinically meaningful effect 
on lumbar spine BMD. 
6 
6 Bjelakovic98 2014 Vitamin D supplementation 
for prevention of mortality 
in adults 
2 Postmeno-
pausal 
women 
and older 
men 
Incep-
tion-
2012 
5 to 7 
years 
Vitamin D  Placebo 
or no in-
terven-
tion 
Cancer 
mortality 
RR=0.88 (95% 
CI: 0.78 to 
0.98) 
Vitamin D3 statistically signif-
icantly decreased cancer 
mortality; based on moderate 
quality evidence 
11 
7 Husebo99 2016 Identifying and Managing 
Pain in People with Alz-
heimer’s Disease and 
Other Types of Dementia: 
A Systematic Review 
2 Advanced 
dementia 
patients 
1990-
2015 
6 
months 
Cholecal-
ciferol 
Placebo Pain p>0.10 for all 
pain measures 
Pain scores not changed af-
ter vitamin D treatment 
7 
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8a Poscia90 2017 Effectiveness of nutritional 
interventions addressed to 
elderly persons: umbrella 
systematic review with 
meta-analysis 
2 ≥65 years 
old 
2000 
to 
2016 
1 to 66 
months 
Vitamin D 
only 
Placebo 
or cal-
cium only 
or no in-
terven-
tion 
Falls  Kalyani 2010: 
RR=0.94 (95% 
CI 0.77 to 
1.15); Bischoff-
Ferrari 2009: 
RR=0.81 (95% 
CI 0.71 to 
0.92); Cameron 
2012: RR=0.99 
(95% CI 0.90 to 
1.08) but 
showed a sig-
nificant rate ra-
tio of 0.63 (95% 
CI 0.46 to 
0.86); Neyens 
2011: based on 
one RCT 
OR=0.82 (95% 
CI 0.59 to 1.12) 
and rate ratio of 
0.73 (95% CI 
0.57 to 0.95) 
One SR reported significant 
effect of vitamin D therapy on 
falls. Two SRs reported ef-
fect on rate, and one re-
ported non-significant effect 
on falls.  
4 
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8b Poscia90 2017 Effectiveness of nutritional 
interventions addressed to 
elderly persons: umbrella 
systematic review with 
meta-analysis 
2 ≥65 years 
old 
2000 
to 
2016 
1 to 66 
months 
Vitamin D 
& calcium 
Placebo 
or no in-
terven-
tion 
Falls  Kalyani 2010: 
RR= 0.83, 95% 
CI 0.75 to 
0.92); Bischoff-
Ferrari 2009: 
one study of 
the MA re-
ported 19% 
non significant 
reduction in 
falls; Cameron 
2012: RR=0.82 
(95% CI 0.40 to 
1.66 ) but re-
ported a rate 
ratio of 0.38 
(95% CI 0.20 to 
0.71) 
One SR reported significant 
effect of vitamin D plus cal-
cium  on falls. One reported 
non-significant effect on falls. 
One reported effect on rate 
of falls but not on risk of falls. 
4 
8c Poscia90 2017 Effectiveness of nutritional 
interventions addressed to 
elderly persons: umbrella 
systematic review with 
meta-analysis 
2 ≥65 years 
old 
2000 
to 
2016 
1 to 66 
months 
Vitamin D 
only 
Placebo 
or cal-
cium or 
no inter-
vention 
Fractures 
(hip and 
others)  
Avenell 2014: 
RR=1.12 (95% 
CI 0.98 to 1.29) 
for hip fracture 
and RR= 1.03 
(95% CI 0.90 to 
1.11) for any 
type of fracture 
One SR reported that taking 
vitamin D only is unlikely to 
prevent fractures. 
4 
8d Poscia90 2017 Effectiveness of nutritional 
interventions addressed to 
elderly persons: umbrella 
systematic review with 
meta-analysis 
2 ≥65 years 
old 
2000 
to 
2016 
1 to 66 
months 
Vitamin D 
& calcium 
Placebo 
or no in-
terven-
tion 
Fractures 
(hip and 
others)  
Avenell 2014: 
hip fracture risk 
RR=0.84 (95% 
CI 0.74 to 0.96) 
and risk of any 
type of fracture 
RR=0.95 ( 95% 
CI 0.90 to 0.99)  
Evidence from one SR 
showed that vitamin D taken 
with additional calcium sup-
plements slightly reduces the 
likelihood of hip fractures and 
other types of fracture. 
4 
8e Poscia90 2017 Effectiveness of nutritional 
interventions addressed to 
elderly persons: umbrella 
systematic review with 
meta-analysis 
2 ≥65 years 
old 
2000 
to 
2016 
1 to 66 
months 
Vitamin D 
& calcium 
Placebo 
or no in-
terven-
tion 
All-cause 
mortality 
Avenell 2014: 
RR=0.94 (95% 
CI 0.87 to 1.02) 
Mortality was not adversely 
affected by  vitamin D plus 
Calcium 
4 
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8f Poscia90 2017 Effectiveness of nutritional 
interventions addressed to 
elderly persons: umbrella 
systematic review with 
meta-analysis 
2 ≥65 years 
old 
2000 
to 
2016 
1 to 66 
months 
Vitamin D 
only 
Placebo 
or cal-
cium or 
no inter 
vention 
All-cause 
mortality 
Avenell 2014: 
RR=0.99 (95% 
CI 0.94 to 1.03) 
The SR reported insignificant 
results on mortality as an ad-
verse effect of vitamin D sup-
plementation 
4 
9a Scragg91 2012 Do we need to take cal-
cium with vitamin D to pre-
vent falls, fractures and 
death? 
2 ≥60 years 
old 
2007 
to 
2012 
3 to 36 
months 
Vitamin D 
with or 
without 
calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Falls  Bischoff-Ferrari 
2009: RR=0.81 
(95% CI 0.71 to 
0.92); Cameron 
(updated in 
2012): 
RR=0.99 (95% 
CI 0.90 to 1.08) 
but showed a 
significant rate 
ratio of 0.63 
(95% CI 0.46 to 
0.86); Michael 
2010: RR= 
0.83 (95% 
CI0.77 to 0.89) 
 3 SRs reported that vitamin 
D reduces either the risk or 
rate of falls. 
1 
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9b Scragg91 2012 Do we need to take cal-
cium with vitamin D to pre-
vent falls, fractures and 
death? 
2 ≥60 years 
old  
2007 
to 
2012 
1 to 84 
months 
Vitamin D 
with or 
without 
calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Fractures Bischoff-Ferrari 
2009: RR=0.86 
(95% CI 0.77 to 
0.96) for non-
vertebral frac-
ture and 
RR=0.91 (95% 
CI: 0.78 to 
1.05) for hip 
fracture ; 
Avenell 2009:  
RR=1.01 (95% 
CI 0.93 to 1.09) 
for total frac-
ture, significant 
results only for 
vitamin D plus 
Calcium for  hip 
fracture risk 
RR=0.84 (95% 
CI 0.73 to 
0.96); Sawka 
2009:  
RR=0.86 (95% 
CI 0.74 to 0.98) 
hip fracture ; 
Chung:  total 
fracture  vita-
min D plus cal-
cium RR=0.88 
(95% CI0.79 to 
0.99) Vitamin D 
only RR=1.03 
(95% CI0.84 to 
1.26) 
Two SRs concluded that vita-
min D was only beneficial 
when combined with calcium. 
In contrast, the other two 
SRs concluded that vitamin 
D alone was beneficial only 
in doses exceeding 482 IU 
per day. 
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9c Scragg91 2012 Do we need to take cal-
cium with vitamin D to pre-
vent falls, fractures and 
death? 
2 ≥60 years 
old 
2007 
to 
2012 
Maxi-
mum 
60 
months 
Vitamin D 
with or 
without 
calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
All-cause 
mortality 
Avenell 2009: 
RR=0.94 (95% 
CI 0.89 to 0.99) 
vitamin D plus 
Ca, RR=1.01 
(95% CI 0.95 to 
1.06) for vita-
min D alone; 
Rejnmark 
2012: RR=0.93 
(95% CI 0.88 to 
0.99) for vita-
min D with or 
without Ca, 
RR=0.92 (95% 
CI 0.85 to 1.00) 
for vitamin D 
plus Ca, 
RR=0.99 (95% 
CI 0.89 to 1.09) 
for vitamin D 
alone 
Both SRs included found that 
combined vitamin D and cal-
cium supplementation de-
creases all-cause mortality. 
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10a Stubbs 93 2015 What works to prevent 
falls in older adults dwell-
ing in long term care facili-
ties and hospitals? An um-
brella review of meta-anal-
yses of randomised con-
trolled trials. 
2 ≥60 years 
old in care 
facilities 
Incep-
tion  to 
2014 
Not re-
ported 
Vitamin D 
with or 
without 
calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Falls Gou 
2013:OR=0.98 
(95% CI 0.79 to 
1.22);Cameron 
2012: RR=0.99 
(95% CI 0.90 to 
1.08) but 
showed a sig-
nificant rate ra-
tio of 0.63 (95% 
CI 0.46 to 
0.86);Kalyani 
2010: RR=0.90 
(95% CI 0.80 to 
1.01); Murad 
2011: OR 0.87 
(95% CI 0.71 to 
1.07); Bolland 
2014: RR= 
0.96 (95% CI 
0.88 to 1.05) 
Only one out of five SRs 
demonstrated a significant 
reduction in the rate of falls. 
Of the remainder, one SR 
demonstrated a trend to-
wards significance and two 
poolings from another SR 
demonstrated a non-signifi-
cant reduction in the risk of 
falling from vitamin D supple-
mentation with and without 
calcium. Given this, evidence 
does not support vitamin D 
supplementation to reduce 
falls in LTCF; based on evi-
dence authors assessed to 
be moderate and high qual-
ity.  
7 
11a Stubbs 88 2015 What Works to Prevent 
Falls in Community-Dwell-
ing Older Adults? Umbrella 
Review of Meta-analyses 
of Randomized Controlled 
Trials 
2  ≥60 years 
old 
Incep-
tion  to 
2014 
Not re-
ported 
Vitamin D 
& calcium 
Placebo 
or no in-
terven-
tion 
Falls  Bolland 2014: 
RR=0.93 (95% 
CI 0.85 to 
1.02); Gou 
2014: RR=0.78 
(95% CI 0.63 to 
0.98);Kalyani 
2010: RR= 
0.83, 95% CI 
0.75 to 0.92); 
Murad 2011: 
OR=0.83 (95% 
CI 0.72 to 0.93) 
SRs concluded that vitamin 
D was  beneficial when com-
bined with calcium in older 
adults 
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11b Stubbs 88 2015 What Works to Prevent 
Falls in Community-Dwell-
ing Older Adults? Umbrella 
Review of Meta-analyses 
of Randomized Controlled 
Trials 
2  ≥65 years 
old 
Incep-
tion  to 
2014 
Not re-
ported 
Vitamin D 
only 
Placebo 
or no in-
terven-
tion  
Falls  Bolland 2014: 
RR=0.96 (95% 
CI 0.88 to 
1.04); Gou 
2014: RR=1.02 
(95% CI 0.80 to 
1.28); Kalyani 
2010: RR= 
0.83 (95% CI 
0.75 to 0.92); 
Murad 2011: 
OR=0.97 (95% 
CI 0.84 to 
1.11); Jackson 
2007: RR=0.92 
(95% CI 0.75 to 
1.12) 
Supplementation with Vita-
min D alone appears to be 
statistically non-effective in  4 
out of 5 SRs. 
7 
12a Medical Ad-
visory 89 
2008 Prevention of Falls and 
Fall Related Injuries in 
Community-Dwelling Sen-
iors 
2 ≥65 years 
old, com-
munity 
dwelling 
2000 
to 
2007 
1 to 6 
months 
Vitamin D 
only 
Placebo 
or no in-
terven-
tion 
Falls  RR=0.94 (95% 
CI 0.77 to 1.14) 
The results of the SR indi-
cated that supplementation 
with vitamin D does not sig-
nificantly reduce the risk of 
falling in the community-
dwelling elderly population 
5 
12b Medical Ad-
visory 89 
2008 Prevention of Falls and 
Fall Related Injuries in 
Community-Dwelling Sen-
iors 
2 ≥65 years 
old, com-
munity 
dwelling 
2000 
to 
2007 
12 
months 
Vitamin D 
& calcium 
Placebo 
or no in-
terven-
tion 
Fall-re-
lated inju-
ries 
RR=0.48 (95% 
CI, 0.12–1.84) 
Supplementation with vitamin 
D does not significantly re-
duce the risk of fall-related 
injuries in the community-
dwelling elderly women. 
5 
12c Medical Ad-
visory 89 
2008 Prevention of Falls and 
Fall Related Injuries in 
Community-Dwelling Sen-
iors 
2 ≥65 years 
old, com-
munity 
dwelling 
2000 
to 
2007 
36 
months 
Vitamin D 
& calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Falls  RR=0.89 (95% 
CI 0.74 to 1.07) 
for men and 
women; 
RR=0.83 (95% 
CI 0.73 to 0.95) 
for women 
only. 
The evidence does not sug-
gest a statistically significant 
reduction in falls in the study 
that included both men and 
women in their study popula-
tion but for the women only 
study population the reduc-
tion in falls was significant. 
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12d Medical Ad-
visory 89 
2008 Prevention of Falls and 
Fall Related Injuries in 
Community-Dwelling Sen-
iors 
2 ≥65 years 
old, com-
munity 
dwelling 
2000 
to 
2007 
1 to 36 
months 
Vitamin D 
& calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Fall-re-
lated frac-
ture 
RR=0.77 (95% 
CI 0.49 to 1.21) 
The evidence does not sug-
gest a statistically significant 
reduction in fall-related inju-
ries in women 
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13a De Spiege-
leer 95 
2018 Pharmacological Interven-
tions to Improve Muscle 
Mass, Muscle Strength 
and Physical Performance 
in Older People: An Um-
brella Review of System-
atic Reviews and 
Meta-analyses 
2 ≥65 years 
old 
Incep-
tion  to 
2017 
Not re-
ported 
Vitamin D 
with or 
without 
calcium 
Placebo 
or no in-
terven-
tion 
Muscle 
strength 
Anagnostis 
2015: Knee ex-
tension: 
SMD=0.05 
(95% CI 0.11–
0.20). (1) 
Global muscle 
strength: 
SMD=0.25 
(95% CI 0.01–
0.48). Institu-
tionalised and 
hospitalised vs. 
community 
dwelling: SMD 
0.45 vs. 0.05; p 
< 0.01 (2) Grip 
strength: 
SMD=0.01 
(95% CI –0.06–
0.07) (3) Lower 
limb muscle 
strength: SMD 
0.19 (95% CI 
0.05–0.34); 
Beaudart 2017: 
Both studies re-
ported no dif-
ference be-
tween the exer-
cise-only group 
and the group 
with combined 
exercise and 
vitamin D sup-
plementation. 
Only 1 out of the 2 included 
SRs found positive effect on 
muscle strength; but authors 
described there is sufficient 
evidence in favour (women). 
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13b De Spiege-
leer 95 
2018 Pharmacological Interven-
tions to Improve Muscle 
Mass, Muscle Strength 
and Physical Performance 
in Older People: An Um-
brella Review of System-
atic Reviews and 
Meta-analyses 
2 ≥65 years 
old 
Incep-
tion  to 
2017 
Not re-
ported 
Vitamin D 
with or 
without 
calcium 
Placebo 
or no in-
terven-
tion 
Physical 
(functional) 
perfor-
mance  
Anagnostis 
2015:TUG: 
SMD= − 0.19 
(95% CI − 0.35 
to − 0.02); p = 
0.03 Gait: an 
effect on gait 
was not found, 
although the 
studies that 
evaluated gait 
were of lower 
methodological 
quality and 
used low doses 
of vitamin D; 
Beaudart 2017: 
Physical perfor-
mance in-
creased, for 
some of the 
physical perfor-
mance out-
comes, in 2/2 
RCTs with no 
additional effect 
of vitamin D, 
except for TUG 
in 1/2 RCTs 
Some evidence in favour of 
improved physical perfor-
mance when supplementing 
with vitamin D. The effects 
are most pronounced when 
supplementing those with se-
rum levels < 10 ng/ml. Rec-
ommended vitamin D supple-
mentation to improve physi-
cal performance in older peo-
ple, especially women, with 
low baseline serum levels.  
5 
14a Vestergaard 
94 
2010 Fracture prevention in 
postmenopausal women 
2 > 60 years 
old women 
Incep-
tion  to 
2010 
1 to 5 
years 
Vitamin D 
only 
Placebo 
or no in-
terven-
tion 
Vertebral 
fracture  
Avenell 2009: 
RR=0.90 (95% 
CI 0.42 to 1.92) 
Compared with placebo or 
no treatment Vitamin D 
seems no more effective at 
reducing vertebral fractures 
in women and in men aged 
over 65 years (moderate-
quality evidence). 
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14b Vestergaard 
94 
2010 Fracture prevention in 
postmenopausal women 
2 > 60 years 
old women 
Incep-
tion  to 
2010 
1 to 5 
years 
Vitamin D 
only 
Placebo 
or no in-
terven-
tion 
Non-verte-
bral frac-
ture  
Avenell 2009: 
hip fracture 
RR=1.15 (95% 
CI 0.99 to 
1.33); Dipart 
2010 : 
HR=1.09 (95% 
CI 0.92 to 1.29) 
Compared with placebo or 
no treatment Vitamin D 
seems no more effective at 
reducing any non-vertebral 
fracture or hip fracture in 
postmenopausal women and 
in men aged over 65 years 
(moderate-quality evidence). 
6 
14c Vestergaard 
94 
2010 Fracture prevention in 
postmenopausal women 
2 > 60 years 
old women 
Incep-
tion  to 
2010 
1 to 5 
years 
Vitamin D 
& calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Vertebral 
fracture  
Avenell 2009: 
RR=0.91 (95% 
CI 0.75 to 1.11; 
Dipart 2010 : 
HR=0.85 (95% 
CI 0.66 to 1.11) 
Compared with placebo or 
no treatment Calcium plus 
vitamin D may be no more 
effective at reducing the risk 
of vertebral fractures in post-
menopausal women or in 
men aged over 65 years 
(low-quality evidence) 
6 
14d Vestergaard 
94 
2010 Fracture prevention in 
postmenopausal women 
2 > 60 years 
old women 
Incep-
tion  to 
2010 
1 to 5 
years 
Vitamin D 
& calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Non-verte-
bral frac-
ture  
Avenell 2009: 
RR=0.95 (95% 
CI 0.90 to 
1.00); Dipart 
2010:  hip frac-
ture HR=0.84 
(95% CI 0.70 to 
1.01;); Bischoff-
Ferrari 2009: 
RR= 0.77 ( 
95% CI 0.68 to 
0.87) 
Compared with placebo or 
no treatment Calcium plus 
vitamin D may be more ef-
fective at reducing the risk of 
nonvertebral fractures in 
postmenopausal women or 
in men aged over 65 years 
(low-quality evidence). 
6 
 HTA Scoping Report 82 
C
od
e 
fo
r a
na
ly
si
s 
(s
ee
 a
pp
en
di
x 
7)
 Main author Year Title 
FC
N
 a
t r
is
k 
gr
ou
p 
FCN at risk 
group 
(subgroup) 
Meth-
ods 
(Time 
range 
of re-
view) 
Dura-
tion of 
follow-
up of 
in-
cluded 
studies 
Interven-
tion(s) 
Compar-
ator(s) 
Outcomes 
relevant to 
our analy-
sis  
Results* Summary 
AM
ST
AR
 
sc
or
e*
* 
15a Theodora-
tou 92 
2014 Vitamin D and multiple 
health outcomes: umbrella 
review of systematic re-
views and meta-analyses 
of observational studies 
and randomised trials 
2 > 60 years 
old 
Incep-
tion to 
2013 
Maxi-
mum 
48 
months 
Vitamin D 
with or 
without 
calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Falls OR=0.97 (95% 
CI  0.84 to 
1.11) 
11 SRs examined risk of fall-
ing, and differences existed 
in both the magnitude and 
the statistical significance of 
the effect but not in the direc-
tion of the effect. Finally, 
three meta-analyses exam-
ined rate of falls, and differ-
ences existed in the direc-
tion, magnitude, and statisti-
cal significance of the effect. 
The MA of non overlapping 
MAs reported non significant 
effect. 
3 
15b Theodora-
tou 92 
2014 Vitamin D and multiple 
health outcomes: umbrella 
review of systematic re-
views and meta-analyses 
of observational studies 
and randomised trials 
2 > 60 years 
old 
Incep-
tion to 
2013 
Maxi-
mum 
48 
months 
Vitamin D 
with or 
without 
calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Fractures RR=1.01 (95% 
CI: 0.93 to 
1.09) 
10 SRs reported conflicting 
results. The MA of non over-
lapping MAs reported non 
significant effect. 
3 
15c Theodora-
tou 92 
2014 Vitamin D and multiple 
health outcomes: umbrella 
review of systematic re-
views and meta-analyses 
of observational studies 
and randomised trials 
2 > 60 years 
old 
Incep-
tion to 
2013 
3 to 24 
months 
Vitamin D 
with or 
without 
calcium 
Placebo 
or cal-
cium or 
no inter-
vention 
Physical 
perfor-
mance 
(balance 
sway/lower 
extremity 
strength) 
Balance sway 
SMD= -0.20 
(95% CI  -0.39 
to -0.01); lower 
extremity 
strength: 
SMD=0.05 
(95% CI  -0.11 
to 0.20) 
Improved balance sway (sig-
nificant effect) and lower ex-
tremity strength (non-signifi-
cant effect) when supple-
menting with vitamin D. 
3 
 OBESE INDIVIDUALS 
16 Bassatne 103 2019 Vitamin D supplementation 
in obesity and during 
weight loss: A review of 
randomized controlled tri-
als. 
3 Mean BMI 
of partici-
pants 
≥30 kg/m2 
in at least 
one arm) 
without 
weight loss 
2010-
2018 
12 
months 
Vitamin 
D3 
Placebo Bone min-
eral den-
sity 
No significant 
differences 
were found be-
tween the three 
groups regard-
ing change in 
BMD 
There were no significant 
changes in BMD between 
nor within treatment arms. 
Furthermore, in the protocol 
of the one RCT included, 
BMD was not pre-specified in 
the trial protocol 
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 PREGNANT WOMEN 
17a Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
n/a Vitamin D 
mono-
therapy 
pla-
cebo/no 
interven-
tion 
Pre-ec-
lampsia 
n/a No trials were found evaluat-
ing effect of intervention in 
high-income setting  
11 
17b Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
3 
months 
Vitamin D 
mono-
therapy 
pla-
cebo/no 
interven-
tion 
low birth-
weight 
(less than 
2500 g) 
(RR 0.53, 95% 
CI 0.23 to 1.21; 
Only one trial from high-in-
come country setting on ef-
fect of vitamin D monother-
apy on low birthweight; which 
was published in 1980 and 
supplemented women of 
Asian origin only 
11 
17c Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
3 to 6 
months 
Vitamin D 
mono-
therapy 
pla-
cebo/no 
interven-
tion 
preterm 
birth < 37 
weeks 
(RR 0.66, 95% 
CI 0.34 to 1.30; 
Vitamin D supplementation 
may make little or no differ-
ence in the risk of having a 
preterm birth < 37 weeks 
(low‐certainty evidence) 
11 
17d Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
n/a Vitamin D 
mono-
therapy 
pla-
cebo/no 
interven-
tion 
Maternal 
gestational 
diabetes 
n/a No trials were found evaluat-
ing effect of intervention in 
high-income setting  
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17e Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
n/a Vitamin D 
and cal-
cium  
pla-
cebo/no 
interven-
tion 
pre‐ec-
lampsia 
n/a No trials were found evaluat-
ing effect of intervention in 
high-income setting  
11 
17f Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
n/a Vitamin D 
and cal-
cium  
pla-
cebo/no 
interven-
tion 
maternal 
gestational 
diabetes 
n/a No trials were found evaluat-
ing effect of intervention in 
high-income setting  
11 
17g Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
n/a Vitamin D 
and cal-
cium  
pla-
cebo/no 
interven-
tion 
low birth-
weight 
(less than 
2500 g) 
n/a No trials were found evaluat-
ing effect of intervention in 
high-income setting  
11 
17h Browne 
(and De-Re-
gil) 104 
2016 
(with 
2019 
update 
of in-
cluded 
SR 
pre-
sented) 
Vitamin D supplementation 
for women during preg-
nancy 
4 Pregnant 
women 
Incep-
tion to 
2018 
n/a Vitamin D 
and cal-
cium  
pla-
cebo/no 
interven-
tion 
preterm 
birth < 37 
weeks 
n/a No trials were found evaluat-
ing effect of intervention in 
high-income setting  
11 
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18 Harvey 106 2014 Vitamin D supplementation 
in pregnancy: A systematic 
review 
4 Pregnant 
women 
Incep-
tion to 
2012 
circa 3 
months 
Vitamin D 
and cal-
cium  
no inter-
vention 
Offspring 
forearm 
bone min-
eral con-
tent 
Mean bone 
mass outcome 
of 3.10 units in 
comparator 
group; 3.19 
units in inter-
vention group. 
No p value 
given 
There was no significant dif-
ference in the bone mineral 
content (as assessed by 
photon absorptiometry) of 
the forearms of babies born 
to these women between the 
intervention and comparator 
groups. The study was as-
sessed to have a high risk of 
bias 
8 
19a Cranney 33 2007 Effectiveness and safety of 
vitamin D in relation to 
bone health 
4 Women of 
reproduc-
tive age 
Incep-
tion-
2006 
n/a Vitamin D Control Bone min-
eral den-
sity 
n/a No trials were found evaluat-
ing effect of intervention on 
BMD in any setting for preg-
nant women 
7 
19b Cranney 33 2007 Effectiveness and safety of 
vitamin D in relation to 
bone health 
4 Women of 
reproduc-
tive age 
Incep-
tion-
2006 
n/a Vitamin D Control Fractures n/a No trials were found evaluat-
ing effect of intervention on 
fractures in any setting for 
pregnant women 
7 
 ATHLETES 
20a Farrokhyar 
108 
2017 Effects of Vitamin D Sup-
plementation on Serum 
25-Hydroxyvitamin D Con-
centrations and Physical 
Performance in Athletes: A 
Systematic Review and 
Meta-analysis of Random-
ized Controlled Trials 
6 
 
Incep-
tion-
2016 
n/a Vitamin D 
supple-
ment 
Placebo 
or no in-
terven-
tion 
Injury 
(stress 
fractures, 
or muscle 
and con-
nective tis-
sue injury) 
n/a No RCTs were found that 
formally assess the impact of 
vitamin D supplementation in 
preventing injury in athletes. 
However, one trial reported 
16 muscle and connective 
tissue injuries over 24 
weeks, and recorded that 
77% of the injured athletes 
reported the injury after a de-
crease in their vitamin D 
level from baseline. 
9 
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20b Farrokhyar 
108 
2017 Effects of Vitamin D Sup-
plementation on Serum 
25-Hydroxyvitamin D Con-
centrations and Physical 
Performance in Athletes: A 
Systematic Review and 
Meta-analysis of Random-
ized Controlled Trials 
6 
 
Incep-
tion-
2016 
12 
weeks 
Vitamin D 
supple-
ment 
Placebo 
or no in-
terven-
tion 
Physical 
perfor-
mance 
Hand grip 
strength (three 
trials) in-
creased signifi-
cantly (2.56 kg; 
95% CI: 1.00–
4.13) after 12 
weeks’ vitamin 
D supplemen-
tation of 2000–
3800 IU. No 
significant dif-
ferences were 
found in vertical 
jump height 
(0.92 cm; 95% 
CI:-0.55 to 
2.44), one rep-
etition maxi-
mum (1-RM) 
bench press 
(2.05; 95% CI:-
5.5 to 9.6) or 
10- to 30-m 
sprint (0.04 s; 
95% CI:-0.04 to 
0.12) 
Physical performance did not 
significantly improve from vit-
amin D supplementation 
9 
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21a Chiang 109 2017 Effects of Vitamin D Sup-
plementation on Muscle 
Strength in Athletes: A 
Systematic Review 
6 healthy, 
athletic 
partici-
pants aged 
18-45 
years 
2010-
2016 
4 
weeks 
to 6 
months 
Cholecal-
ciferol 
Placebo Muscle 
strength 
In 2 studies, 
strength out-
come 
measures were 
significantly im-
proved after 
supplementa-
tion (p<=0.05). 
In the other 2 
studies admin-
istering vitamin 
D3, there were 
trends for im-
proved muscle 
strength 
Vitamin D3 was shown to 
have a positive impact on 
muscle strength. 
3 
21b Chiang 109 2017 Effects of Vitamin D Sup-
plementation on Muscle 
Strength in Athletes: A 
Systematic Review 
6 healthy, 
athletic 
partici-
pants aged 
18-45 
years 
2010-
2016 
4 
weeks 
to 6 
months 
Ergocal-
ciferol 
Placebo Muscle 
strength 
p>0.05 in each 
of the studies 
Vitamin D2 was found to be 
ineffective at impacting mus-
cle strength in both studies 
wherein it was administered.  
3 
 
Key: MA=meta-analysis, RCT=randomised controlled trial, SR=systematic review, UR=umbrella review, FCN= Swiss Federal Commission for Nutrition at high risk of severe vitamin D deficiency defined by 
FCN group 1 (persons with bone disorders), 2 (older adults), 3 (obese individuals), 4 (pregnant women), 5 (people with dark skin tone), 6 (athletes), RR=relative risk,. RaR=rate ratio. OR=odds ratio. 
HR=hazard ratio. CI=confidence interval. BMD=bone mineral density. SMD=standardized mean difference. BMI=body mass index 
*Direction of the effect size reported is always vitamin D supplementation versus comparator. **A Measurement Tool to Assess systematic Reviews 1 (AMSTAR 1) is a quality assessment tool ranging from 
0 (lowest quality) to 11 (highest quality). ***Some studies appear more than once in table as they address multiple outcomes/vitamin D modalities for a particular risk group.
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Appendix 9. List of excluded studies from full text screening for clinical effectiveness of vitamin D test-
ing (CRQa) 
 
 
Author Date  Title 
INCORRECT FCN AT RISK GROUP 
Balfour, L., et al. 2014 Micronutrient deficiency and treatment adherence in a randomized controlled trial of 
micronutrient supplementation in ART-naive persons with HIV 
Barr, R. J., et al. 2005 Screening elderly women for risk of future fractures--participation rates and impact on 
incidence of falls and fractures 
Daniel, D., et al. 2011 Fibromyalgia--should we be testing and treating for vitamin D deficiency? 
de Oliveira, J. F., et al. 2015 [Vitamin D in children and adolescents with sickle cell disease: an integrative review] 
Derakhshanian, H., et al. 2015 Vitamin D and diabetic nephropathy: A systematic review and meta-analysis 
Lee, M. T., et al. 2018 Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in 
children with sickle cell disease 
Orgel, E., et al. 2017 A randomized controlled trial testing an adherence-optimized Vitamin D regimen to 
mitigate bone change in adolescents being treated for acute lymphoblastic leukemia 
Verheyden, G. S., et al. 2013 Interventions for preventing falls in people after stroke 
INCORRECT SETTING - SOCIO-ECONOMIC DISSIMILAR TO CH 
Chandrashekara, S., et 
al. 
2017 Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: 
An exploratory study 
Nandal, R., et al. 2016 Comparison of cord blood vitamin D levels in newborns of vitamin D supplemented 
and unsupplemented pregnant women: a prospective, comparative study 
Rostami, M., et al. 2018 Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A 
Stratified Randomized Field Trial 
Wallis, R. S., et al. 2016 Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review 
INCORRECT INTERVENTION – NOT VITAMIN D TESTING (I.E. OTHER SCREENING TEST, VITAMIN D SUPPLEMEN-
TATION, ETC.) 
Arnedo-Pena, A., et al. 2014 Vitamin D status and incidence of tuberculosis infection conversion in contacts of pul-
monary tuberculosis patients: A prospective cohort study 
Bjelakovic, G., et al. 2014 Vitamin D supplementation for prevention of mortality in adults 
Brown, T. T., et al. 2015 Vitamin D supplementation does not affect metabolic changes seen with art initiation 
Cameron, I. D., et al. 2018 Interventions for preventing falls in older people in care facilities and hospitals 
Chakhtoura, M. T., et al. 2016 Hypovitaminosis D in bariatric surgery: a systematic review of observational studies 
Chakhtoura, M., et al. 2017 Vitamin D Metabolism in Bariatric Surgery 
Diao, N., et al. 2017 Effect of vitamin D supplementation on knee osteoarthritis: A systematic review and 
meta-analysis of randomized clinical trials 
Ennis, J., et al. 2015 Clinical decision support improves physician guideline adherence for laboratory moni-
toring of chronic kidney disease: A matched cohort study 
Farrokhyar, F., et al. 2017 Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations 
and Physical Performance in Athletes: A Systematic Review and Meta-analysis of 
Randomized Controlled Trials 
Fox, J., et al. 2011 Improvement in vitamin D deficiency following antiretroviral regime change: Results 
from the MONET trial 
Geddes, J., et al. 2013 Evidence for the treatment of osteoporosis with vitamin d in residential care and in the 
community dwelling elderly 
Goulao, B., et al. 2018 Cancer and vitamin D supplementation: a systematic review and meta-analysis 
Hahn, D., et al. 2015 Interventions for metabolic bone disease in children with chronic kidney disease 
Helland, I. B., et al. 2003 Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and 
lactation augments children's IQ at 4 years of age 
Huang, H. Y., et al. 2006 Multivitamin/mineral supplements and prevention of chronic disease 
Izadpanah, M., et al. 2013 Potential benefits of vitamin D supplementation in critically ill patients 
Jamka, M., et al. 2015 The effect of vitamin D supplementation on insulin and glucose metabolism in over-
weight and obese individuals: systematic review with meta-analysis 
Jolliffe, D. A., et al. 2017 Vitamin D supplementation to prevent asthma exacerbations: a systematic review and 
meta-analysis of individual participant data 
Jolliffe, D. A., et al. 2019 Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of 
individual participant data from randomised controlled trials 
Martineau, A. R., et al. 2017 Vitamin D supplementation to prevent acute respiratory tract infections: systematic re-
view and meta-analysis of individual participant data 
Murad, M. H., et al. 2011 Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis 
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Patel, R.;Rizvi, A. A. 2011 Vitamin D deficiency in patients with congestive heart failure: mechanisms, manifesta-
tions, and management 
Rejnmark, L., et al. 2011 Effects of vitamin d on muscle function and performance: a review of evidence from 
randomized controlled trials 
Rejnmark, L., et al. 2017 Non-skeletal health effects of vitamin D supplementation: A systematic review on find-
ings from meta-analyses summarizing trial data 
Swart, K. M., et al. 2018 Effects of vitamin D supplementation on markers for cardiovascular disease and type 
2 diabetes: an individual participant data meta-analysis of randomized controlled trials 
Tang, O., et al. 2018 Design Features of Randomized Clinical Trials of Vitamin D and Falls: A Systematic 
Review 
Thorne-Lyman, A., et al. 2012 Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a 
systematic review and meta-analysis 
Yang, N., et al. 2015 Effects of vitamin D supplementation during pregnancy on neonatal vitamin D and cal-
cium concentrations: a systematic review and meta-analysis 
Zhao, J. G., et al. 2017 Association Between Calcium or Vitamin D Supplementation and Fracture Incidence 
in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis 
Zheng, Y., et al. 2013 Meta-analysis of long-term vitamin D supplementation on overall mortality 
INCORRECT COMPARATOR – NOT PLACEBO OR STANDARD CARE 
Arvold, D. S., et al. 2009 Corelation of symptoms with vitamin D deficiency and symptom response to cholecal-
ciferol treatment: A randomized controlled trial 
Braddy, K. K., et al. 2009 Vitamin D Deficiency/Insufficiency Practice Patterns in a Veterans Health Administra-
tion Long-Term Care Population: A Retrospective Analysis 
Datta, S., et al. 2002 Vitamin D deficiency in pregnant women from a non-European ethnic minority popula-
tion - An interventional study 
Hewitt, N. A., et al. 2013 Effects of cholecalciferol on functional, biochemical, vascular, and quality of life out-
comes in hemodialysis patients 
Hoeck, H. C., et al. 2009 Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopau-
sal females with osteoporosis 
Lake, J. E., et al. 2015 Success of Standard Dose Vitamin D Supplementation in Treated Human Immunode-
ficiency Virus Infection 
Marckmann, P., et al. 2012 Randomized controlled trial of cholecalciferol supplementation in chronic kidney dis-
ease patients with hypovitaminosis D 
INCORRECT OUTCOMES 
Cadth., et al. 2014 Vitamin D toxicity associated with different vitamin D dosing regimens: safety 
INCORRECT STUDY TYPE – CONFERENCE ABSTRACT, REVIEW PAPER, LETTER, EDITORIAL 
Abou-Raya, S., et al. 2013 A randomized controlled trial of early initiation of osteoporosis assessment and man-
agement in the acute setting of the fracture clinic 
Bolland, M. J., et al. 2012 Should measurement of vitamin D and treatment of vitamin D insufficiency be routine 
in New Zealand? 
Bolland, M. J., et al. 2015 Screening for Vitamin D deficiency 
Carsley, S., et al. 2015 Cohort Profile: The Applied Research Group for Kids (TARGet Kids!) 
Holick, M. F., et al. 2011 Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society 
clinical practice guideline  
2011 Committee Opinion No. 495: Vitamin D: Screening and Supplementation During Preg-
nancy 
Hudson, J. Q. 2006 Secondary hyperparathyroidism in chronic kidney disease: focus on clinical conse-
quences and vitamin D therapies 
Kulie, T., et al. 2009 Vitamin D: an evidence-based review 
Libman, H., et al. 2016 Should We Screen for Vitamin D Deficiency?: Grand Rounds Discussion From Beth 
Israel Deaconess Medical Center 
Noe, K., et al. 2008 Bone health and antiseizure drugs: diagnosis and management 
O'Connor, T., et al. 2014 Pelvic Insufficiency Fractures 
Petering, R. ., et al. 2009 Exercise, fluid, and nutrition recommendations for the postgastric bypass exerciser 
Shub, A., et al. 2019 Letter to the Editor: "Effectiveness of Prenatal Vitamin D Deficiency Screening and 
Treatment Program: A Stratified Randomized Field Trial" 
Souberbielle, J. C., et al. 2012 When should we measure vitamin D concentration in clinical practice? 
Yin, M., et al. 2012 Vitamin D, bone, and HIV infection 
INCORRECT STUDY TYPE – ECONOMICS 
Pacis, M. M., et al. 2015 Vitamin D and assisted reproduction: should vitamin D be routinely screened and re-
pleted prior to ART? A systematic review 
INCORRECT STUDY DESIGN- NONRANDOMIZED RCTs, DIDN’T INCLUDE INTERVENTION OF SUPPLEMENTA-
TION OR PLACEBO ARM TO UNDERSTAND THE IMPACT OF SCREENING VERSUS NO SCREENING  
Aucoin, M., et al. 2013 Vitamin D status of refugees arriving in Canada: Findings from the calgary refugee 
health program 
Bailey, B. A., et al. 2012 Vitamin D testing patterns among six Veterans Medical Centers in the southeastern 
United States: links with medical costs 
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Barton, D. W., et al. 2018 Rates of osteoporosis screening and treatment following vertebral fracture 
Benitez-Aguirre, P. Z., et 
al. 
2009 The natural history of vitamin D deficiency in African refugees living in Sydney 
Kerezoudis, P., et al. 2016 Association Between Vitamin D Deficiency and Outcomes Following Spinal Fusion 
Surgery: A Systematic Review 
INCORRECT STUDY TYPE – SCREENING FOR VITAMIN D ONLY TO: REPORT PREVALENCE, VALIDATE SCREEN-
ING TOOL, ETC. 
Davis, L. M., et al. 2010 Vitamin D Insufficiency Is Prevalent among Pregnant African American Adolescents 
De Laine, K. M., et al. 2013 Prospective audit of vitamin D levels of women presenting for their first antenatal visit 
at a tertiary centre 
Johri, N., et al. 2017 Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction 
pose any risk 
LANGUAGE (NON-ENGLISH) 
Feranchak, A. P., et al. 1999 Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis 
identified by newborn screen 
Gonzalez Jimenez, D., 
et al. 
2015 [Vitamin D and Chronic Lung Colonization in Pediatric and Young Adults Cystic Fibro-
sis Patients] 
Mengarelli, C., et al. 2015 Vitamin D screening in adults (Structured abstract) 
EPUB AHEAD OF PRINT (PHYSICAL AND ONLINE PUBLICATION NOT AVAILABLE) 
Inkrott, BP. et al 2016 Hypovitaminosis D in Patients Undergoing Shoulder Arthroplasty: A Single-Center 
Analysis 
Loh, HH. et al 2017 Effect of Vitamin D replacement in Primary Hyperparathyroidism with concurrent Vita-
min D deficiency: a systematic review and meta-analysis 
Eslami, O. et al 2018 Vitamin D and Cardiorespiratory Fitness in the General Population: A Systematic Re-
view 
 
 
Appendix 10. List of excluded economic studies of vitamin D testing from full text screening (CRQb) 
Author Year Title Reason for exclusion 
Bailey et al. 2012 Vitamin D testing patterns among six Veterans 
Medical Centers in the southeastern United States: 
links with medical costs 
incorrect comparator – different number of 
tests 
Basatemeur 
et al. 
2017 Costs of vitamin D testing and prescribing among 
children in primary care 
incorrect population – over 75% of children 
not of dark skin tone 
Bejjanki et 
al. 
2018 The role of a best practice alert in the electronic 
medical record in reducing repetitive lab tests 
incorrect PICOS - intervention electronic, 
not screening 
Bilinski et al. 2013 Evidence of overtesting for vitamin D in Australia: 
an analysis of 4.5 years of Medicare Benefits 
Schedule (MBS) data 
Non-economic study 
Bilinski et al. 2012 The Vitamin D paradox: bone density testing in fe-
males aged 45 to 74 did not increase over a ten-
year period despite a marked increase in testing 
for vitamin D 
Although they do a subgroup analysis for 
65-74, the subgroup analysis is more re-
lated to the clinical rather than the eco-
nomics part of the report. 
CADTH 2014 Vitamin D testing in the general population: clinical 
and cost-effectiveness and guidelines 
This is a relevant HTA, but the only rele-
vant economic evaluation the HTA re-
ported was identified separately in our 
search (i.e. Lee et al). We Included this 
HTA in the clinical review of vitamin D test-
ing. 
Health Qual-
ity, Ontario 
2010 Clinical utility of vitamin d testing: an evidence-
based analysis 
Non-economic study  
Johnson et 
al. 
2015 Yield and cost-effectiveness of laboratory testing 
to identify metabolic contributors to falls and frac-
tures in older persons 
incorrect intervention 
Morgen et 
al. 
2015 Inappropriate repeats of six common tests in a Ca-
nadian city: A population cohort study within a La-
boratory Informatics framework 
Incorrect population. 
Naugler et 
al. 
2017 Implementation of an intervention to reduce popu-
lation-based screening for vitamin D deficiency: a 
cross-sectional study 
Non-economic study 
Pacis et al. 2015 Vitamin D and assisted reproduction: should vita-
min D be routinely screened and repleted prior to 
ART? A systematic review 
incorrect population – women undergoing 
IVF, therefore not yet pregnant 
Wei et al. 2014 Insignificant medium-term vitamin D status change 
after 25-hydroxyvitamin D testing in a large man-
aged care population 
Non-economic study 
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Appendix 11. List of excluded studies with reasons for exclusion, from full text screening for clinical 
effectiveness of vitamin D supplementation (URQ) 
 
Author Year Title 
INCORRECT POPULATION (E.G. CARDIOVASCULAR, DIABETES, CANCER).  
Alvarez, J. A., et al.  2012 Vitamin D supplementation in pre-dialysis chronic kidney disease: A systematic 
review 
Annweiler, C., et al. 2013 Meta-analysis of memory and executive dysfunctions in relation to vitamin D 
Antakia, R., et al. 2015 Effectiveness of Preventative and Other Surgical Measures on Hypocalcemia 
Following Bilateral Thyroid Surgery: A Systematic Review and Meta-Analysis 
Ash, S., et al.  2014 Nutrition prescription to achieve positive outcomes in Chronic Kidney Disease: 
A systematic review 
Bagur, M. J., et al. 2017 Influence of Diet in Multiple Sclerosis: A Systematic Review 
Barber, G. A., et al. 2018 Effects and associations of nutrition in patients with venous leg ulcers: A sys-
tematic review 
Batchelor, F., et al. 2010 What works in falls prevention after stroke?: A systematic review and meta-
analysis 
Bath-Hextall, F. J., et al. 2012 Dietary supplements for established atopic eczema 
Beaudart, C., et al. 2017 Nutrition and physical activity in the prevention and treatment of sarcopenia: 
systematic review 
Bergman, P., et al. 2013 Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-
Analysis of Randomized Controlled Trials 
Bjelakovic,,G., et al. 2017 Vitamin D supplementation for chronic liver diseases in adults 
Büttner, M., et al. 2017 Quality of life in patients with hypoparathyroidism receiving standard treatment: 
a systematic review 
Suetonia, C. P., et al. 2007 Interventions for preventing bone disease in kidney transplant recipients 
Caini, S., et al. 2014 Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a 
comprehensive review and meta-analysis 
Carroll, C., et al. 2010 Supplemental calcium in the chemoprevention of colorectal cancer: A system-
atic review and meta-analysis 
Charan, J., et al. 2012 Vitamin D for prevention of respiratory tract infections: A systematic review and 
meta-analysis 
Cheng, J., et al. 2012 Efficacy and safety of paricalcitol therapy for chronic kidney disease: A meta-
analysis 
Cicero, A. F. G., et al. 2017 Nutraceuticals and dietary supplements to improve quality of life and outcomes 
in heart failure patients 
Daniel, D., et al. 2011 Fibromyalgia - should we be testing and treating for vitamin D deficiency? 
De Borst, M. H., et al.  2013 Active vitamin D treatment for reduction of residual proteinuria: A systematic re-
view 
De Medeiros, M. C. S., 
et al. 
2018 Dietary Intervention And Health In Patients With Systemic Lupus Erythemato-
sus: A Systematic Review Of The Evidence 
Edafe, O., et al. 2014 Systematic review and meta-analysis of predictors of post-thyroidectomy hy-
pocalcaemia 
Fares, M. M., et al. 2015 Vitamin D supplementation in children with asthma: a systematic review and 
meta-analysis 
Farinotti M., et al. 2012 Dietary interventions for multiple sclerosis 
Feneis, J. F, et al. 2010 Role of vitamin D in blood pressure homeostasis 
Fortmann, S. P., et al. 2013 Vitamin and mineral supplements in the primary prevention of cardiovascular 
disease and cancer: An updated systematic evidence review for the U.S. pre-
ventive services task force 
Franco, A. S., et al. 2017 Vitamin D supplementation and disease activity in patients with immune-medi-
ated rheumatic diseases 
Franco, A. S., et al. 2017 Vitamin D supplementation and disease activity in patients with immune-medi-
ated rheumatic diseases: A systematic review and meta-analysis 
Gaikwad, M., et al. 2017 Does vitamin D supplementation alleviate chronic nonspecific musculoskeletal 
pain? A systematic review and meta-analysis 
Gorham, E. D., et al. 2005 Vitamin D and prevention of colorectal cancer 
Goulao, B., et al. 2018 Cancer and Vitamin D supplementation: A systematic review and meta-analysis 
Gowda, U., et al. 2015 Vitamin D supplementation to reduce depression in adults: Meta-analysis of 
randomized controlled trials 
Grace-Farfaglia, P, et al. 2015 Bones of contention: Bone mineral density recovery in celiac disease-A sys-
tematic review 
Gysin, D. V., et al. 2016 Effect of Vitamin D3 supplementation on respiratory tract infections in healthy 
individuals: A systematic review and meta-Analysis of randomized controlled tri-
als 
H. Y. Huang, H. Y., et al. 2006 Multivitamin/mineral supplements and prevention of chronic disease 
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Hassan, A. B., et al. 2018 Therapeutic and maintenance regimens of vitamin D3 supplementation in 
healthy adults: A systematic review 
Heine-Broring, R. C., et 
al. 
2015 Dietary supplement use and colorectal cancer risk: A systematic review and 
meta-analyses of prospective cohort studies 
Hempel, S., et al. 2017 A systematic review of the effects of modifiable risk factor interventions on the 
progression of multiple sclerosis 
Hossain, S., et al. 2019 Vitamin D and breast cancer: A systematic review and meta-analysis of obser-
vational studies 
Hough, J. P., et al. 2010 Systematic review of interventions for low bone mineral density in children with 
cerebral palsy 
Huang, C. M., et al. 2018 Effects of Vitamin D levels and supplementation on atopic dermatitis: A system-
atic review 
Hujoel, P. P., et al. 2013 Vitamin D and dental caries in controlled clinical trials: Systematic review and 
meta-analysis 
Ibanez-Vera, A. J., et al. 2018 Therapeutic physical exercise and supplements to treat fibromyalgia 
Irlam, J. H., et al. 2010 Micronutrient supplementation in children and adults with HIV infection 
Irlam, J. H., et al.  2013 Micronutrient supplementation for children with HIV infection 
Izadpanah, M, et al. 2013 Potential benefits of vitamin D supplementation in critically ill patients 
Izaks, G. J, et al. 2007 Fracture prevention with vitamin D supplementation: Considering the incon-
sistent results 
J. Wang, J., et al. 2018 Efficacy and Safety of Vitamin D Supplementation for Pulmonary Tuberculosis: 
A Systematic Review and Meta-analysis 
Jagannath V. A., et al. 2010 Vitamin D for the management of multiple sclerosis 
Jagannath, V. A., et al. 2010 Vitamin D for the management of multiple sclerosis 
Jagannath, V. A., et al. 2018 Vitamin D for the management of multiple sclerosis 
James, E., et al. 2013 The effect of vitamin D-related interventions on multiple sclerosis relapses: A 
meta-analysis 
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